Next Article in Journal
Xanthophylls from the Sea: Algae as Source of Bioactive Carotenoids
Next Article in Special Issue
Sphingolipids of Asteroidea and Holothuroidea: Structures and Biological Activities
Previous Article in Journal
Cytotoxic Polyketide Metabolites from a Marine Mesophotic Zone Chalinidae Sponge-Associated Fungus Pleosporales sp. NBUF144
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Triterpene Glycosides from the Far Eastern Sea Cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin): The Structures, Cytotoxicities, and Biogenesis of Kurilosides A3, D1, G, H, I, I1, J, K, and K1

by
Alexandra S. Silchenko
,
Anatoly I. Kalinovsky
,
Sergey A. Avilov
,
Pelageya V. Andrijaschenko
,
Roman S. Popov
,
Pavel S. Dmitrenok
,
Ekaterina A. Chingizova
and
Vladimir I. Kalinin
*
G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Pr. 100-letya Vladivostoka 159, 690022 Vladivostok, Russia
*
Author to whom correspondence should be addressed.
Mar. Drugs 2021, 19(4), 187; https://doi.org/10.3390/md19040187
Submission received: 25 February 2021 / Revised: 16 March 2021 / Accepted: 24 March 2021 / Published: 27 March 2021

Abstract

:
Nine new mono-, di-, and trisulfated triterpene penta- and hexaosides, kurilosides A3 (1), D1 (2), G (3), H (4), I (5), I1 (6), J (7), K (8), and K1 (9) and two desulfated derivatives, DS-kuriloside L (10), having a trisaccharide branched chain, and DS-kuriloside M (11), having hexa-nor-lanostane aglycone with a 7(8)-double bond, have been isolated from the Far-Eastern deep-water sea cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin) and their structures were elucidated based on 2D NMR spectroscopy and HR-ESI mass-spectrometry. Five earlier unknown carbohydrate chains and two aglycones (having a 16β,(20S)-dihydroxy-fragment and a 16β-acetoxy,(20S)-hydroxy fragment) were found in these glycosides. All the glycosides 19 have a sulfate group at C-6 Glc, attached to C-4 Xyl1, while the positions of the other sulfate groups vary in different groups of kurilosides. The analysis of the structural features of the aglycones and the carbohydrate chains of all the glycosides of T. kurilensis showed their biogenetic relationships. Cytotoxic activities of the compounds 19 against mouse neuroblastoma Neuro 2a, normal epithelial JB-6 cells, and erythrocytes were studied. The highest cytotoxicity in the series was demonstrated by trisulfated hexaoside kuriloside H (4), having acetoxy-groups at C(16) and C(20), the latter one obviously compensated the absence of a side chain, essential for the membranolytic action of the glycosides. Kuriloside I1 (6), differing from 4 in the lacking of a terminal glucose residue in the bottom semi-chain, was slightly less active. The compounds 13, 5, and 8 did not demonstrate cytotoxic activity due to the presence of hydroxyl groups in their aglycones.

1. Introduction

The investigations of the triterpene glycosides from different species of sea cucumbers have a range of goals. Among them are the drug discoveries based on the promising candidates, demonstrating the target bioactivity [1,2,3,4,5,6], the solving of some taxonomic problems of the class Holothuroidea based on the specificity of the glycosides having characteristic structural peculiarities for the certain systematic groups [7,8,9,10], the ascertaining of biologic and ecologic functions of these metabolites [11,12,13,14,15], and the discovery of novel compounds, especially minor ones, that can be the “hot metabolites” clarifying the biosynthetic pathways of triterpene glycosides [16,17,18].
As a continuation of our investigation of glycoside composition of the sea cucumber Thyonidium (=Duasmodactuyla) kurilensis (Levin), we report herein the isolation and structure elucidation of nine glycosides, kurilosides A3 (1), D1 (2), G (3), H (4), I (5), I1 (6), J (7), K (8), and K1 (9) as well as two desulfated derivatives, DS-kuriloside L (10) and DS-kuriloside M (11). The animals were collected near Onekotan Island in the Sea of Okhotsk. The structures of the compounds 111 were established by the analyses of the 1H, 13C NMR, 1D TOCSY, and 2D NMR (1H,1H-COSY, HMBC, HSQC, ROESY) spectra as well as HR-ESI mass spectra. All the original spectra are presented in Figures S1–S85 in the Supplementary Materials. The hemolytic activities against mouse erythrocytes, cytotoxic activities against mouse neuroblastoma Neuro 2a, and normal epithelial JB-6 cells have been reported.

2. Results and Discussion

2.1. Structural Elucidation of the Glycosides

The concentrated ethanolic extract of the sea cucumber Thyonidium (=Duasmodactyla) kurilensis was chromatographed on a Polychrom-1 column (powdered Teflon, Biolar, Latvia). The glycosides were eluted with 50% EtOH and separated by repeated chromatography on Si gel columns using CHCl3/EtOH/H2O (100:100:17) and (100:125:25) as mobile phases to give five fractions (I–V). The glycosides 19 (Figure 1) were isolated as a result of subsequent HPLC of the fractions II–V on a reversed-phase semipreparative column Phenomenex Synergi Fusion RP (10 × 250 mm).
The molecular formula of kuriloside A3 (1) was determined to be C54H87O29SNa from the [MNa − Na] ion peak at m/z 1231.5063 (calc. 1231.5059) in the (−)HR-ESI-MS. Kuriloside A3 (1) as well as the reported earlier kurilosides A, A1, and A2 [19] belong to the same group of glycosides, so these compounds have the identical monosulfated pentasaccharide chains that were confirmed by the coincidence of their 1H and 13C NMR spectra corresponding to the carbohydrate chains (Table S1). The presence of five characteristic doublets at δH = 4.64–5.18 (J = 7.1–7.6 Hz), and corresponding signals of anomeric carbons at δC = 102.3–104.7 in the 1H and 13C NMR spectra of the carbohydrate part of 1 indicate the presence of a pentasaccharide chain and β-configurations of the glycosidic bonds. Monosaccharide composition of 1, established by the analysis of the 1H,1H-COSY, HSQC, and 1D TOCSY spectra, includes one xylose (Xyl1), one quinovose (Qui2), two glucoses (Glc3 and Glc4), and one 3-O-methylglucose (MeGlc5) residue. The signal of C-6 Glc4 was observed at δC = 67.1 due to α-shifting effect of a sulfate group at this position. The positions of interglycosidic linkages were established by the ROESY and HMBC spectra (Table S1). The analysis of NMR spectra of the aglycone part of 1 (Table S2) indicated the presence of 22,23,24,25,26,27-hexa-nor-lanostane aglycone with a 16α-hydroxy,20-oxo-fragment and 9(11)-double bond due to the characteristic signals: (δC 149.0 (C-9) and 114.2 (C-11), δC = 71.1 (C-16) and δH = 5.40 (brt, J = 7.5 Hz, H-16), δC = 208.8 (C-20)). The ROE correlations H-16/H-15β and H-16/H-18 indicated a 16α-OH orientation in the aglycone of kuriloside A3 (1). 17αH-orientation, common for the sea cucumber glycosides, was deduced from the ROE-correlation H-17/H-32. The same aglycone was found earlier in kuriloside F [19].
The (−)ESI-MS/MS of 1 demonstrated the fragmentation of [MNa − Na] ion at m/z 1231.5. The peaks of fragment ions were observed at m/z 1069.5 [MNa – Na − C6H10O5 (Glc)], 1055.4 [MNa – Na − C7H12O5(MeGlc)], 923.4 [MNa − Na − C6H10O5(Glc) − C6H10O4(Qui)], 747.3 [MNa − Na − C6H10O5(Glc) − C6H10O4(Qui) − C7H12O5(MeGlc)], 695.1 [MNa −Na − C24H37O3(Agl) − C6H10O5 (Glc) − H], 565.1 [MNa − Na − C24H37O2(Agl) − C6H10O5(Glc) − C6H10O4 (Qui) − H], 549.1 [MNa − Na − C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − H], 417.1 [MNa – Na − C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [MNa − Na − C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − C7H12O5(MeGlc) − H], corroborating the structure of kuriloside A3 (1).
All these data indicate that kuriloside A3 (1) is 3β-O-{β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16α-hydroxy,20-oxo-lanost-9(11)-ene.
The molecular formula of kuriloside D1 (2) was determined to be C66H107O36SNa from the [MNa − Na] ion peak at m/z 1507.6291 (calc. 1507.6268) in the (−)HR-ESI-MS. The hexasaccharide monosulfated carbohydrate chain of 2 was identical to that of previously reported kuriloside D [19] since their 1H and 13C NMR spectra corresponding to the carbohydrate moieties were coincident (Table S3). Actually, six signals of anomeric doublets at δH = 4.70–5.28 (d, J = 7.5–8.2 Hz) and corresponding signals of anomeric carbons at δC = 103.7–105.7 indicated the presence of a hexasaccharide chain in kuriloside D1 (2). The presence of xylose (Xyl1), quinovose (Qui2), three glucose (Glc3, Glc4, Glc5), and 3-O-methylglucose (MeGlc6) residues were deduced from the analysis of the 1H,1H-COSY, HSQC, and 1D TOCSY spectra of 2. The positions of the interglycosidic linkages were elucidated based on the ROESY and HMBC correlations (Table S3). The presence in the 13C NMR spectrum of kuriloside D1 (2) of the only signal of the O-methyl group at δC 60.5 and the upfield shift of the signal of C-3 Glc4 to δC 71.5 indicated the presence of a non-methylated terminal Glc4 residue. Analysis of the 1H and 13C NMR spectra of the aglycone part of 2 indicated the presence of a lanostane aglycone (the signals of lactone ring are absent and the signals of methyl group C-18 are observed at δC 16.9 and δH 1.30 (s, H-18) with normal side chain (30 carbons) and 9(11)-double bond (the signals at δC 149.0 (C-9), 114.9 (C-11), and δH 5.35 (brd, J = 6.2 Hz; H-11) (Table 1). The comparison of the 13C NMR spectra of 2 and kuriloside D showed their great similarity, except for the signals of the side chain from C-23 to C-27. Two strongly deshielded signals at δC 216.3 (C-16) and 217.6 (C-22) corresponded to carbonyl groups, whose positions were established on the base of the HMBC correlations H-15/C-16, H-21/C-22, H-23/C-22, and H-24/C-22. The signals of protons assigned to the methylene group adjacent to 22-oxo group were deshielded to δH 3.67 (dd, J = 10.6; 18.2 Hz; H-23a) and 3.43 (dt, J = 7.8; 18.2 Hz; H-23b) and correlated in the 1H,1H-COSY spectrum of 2 with one signal only at δH 2.27 (t, J = 7.8 Hz; H-24). These data, along with the deshielded signal of quaternary carbon at δC 69.0 (C-25) and the almost coinciding signals of methyl groups C-26 and C-27 (δC 30.0 and 29.5, δH 1.42 and 1.41, correspondingly), indicated the attachment of the hydroxy-group to C-25. Therefore, the side chain of kuriloside D1 (2) is characterized by the 22-oxo-25-hydroxy-fragment (Table 1).
The (−)ESI-MS/MS of 2 demonstrated the fragmentation of [MNa − Na] ion at m/z 1507.6. The peaks of fragment ions were observed at m/z 1349.5 [MNa − Na − C8H15O3 + H], corresponding to the loss of the aglycone fragment from C(20) to C(27), 1187.5 [MNa − Na − C8H15O3 − C6H10O5(Glc) + H], 1025.4 [MNa − Na − C8H15O3 − C6H10O5(Glc) − C6H10O5 (Glc) + H], 879.4 [MNa − Na − C8H15O3 − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) + H], 565.1 [MNa − Na − C30H47O4(Agl) − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) − H], 417.1 [MNa − Na − C30H47O5(Agl) − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [MNa − Na − C30H47O5(Agl) − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − C7H12O5(MeGlc) − H], corroborating the structure of kuriloside D1 (2).
All these data indicate that kuriloside D1 (2) is 3β-O-{β-d-glucopyranosyl-(1→3)-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-16,22-dioxo-25-hydroxylanost-9(11)-ene.
The molecular formula of kuriloside G (3) was determined to be C61H98O37S2Na2 from the [M2Na − Na] ion peak at m/z 1509.5102 (calc. 1509.5132) and the [M2Na − 2Na]2− ion-peak at m/z 743.2624 (calc. 743.2626) in the (−)HR-ESI-MS. In the 1H and 13C NMR spectra of the carbohydrate part of kuriloside G (3), six characteristic doublets at δH 4.65–5.19 (J = 7.0–8.1 Hz) and signals of anomeric carbons at δC 102.1–104.8, correlated with each anomeric proton by the HSQC spectrum, were indicative of a hexasaccharide chain and β-configurations of glycosidic bonds (Table 2). The signals of each monosaccharide unit were found as an isolated spin system based on the 1H,1H-COSY, and 1D TOCSY spectra of 3. Further analysis of the HSQC and ROESY spectra resulted in the assigning of the monosaccharide residues as one xylose (Xyl1), one quinovose (Qui2), two glucoses (Glc3 and Glc5), and two 3-O-methylglucose (MeGlc4 and MeGlc6) residues.
The positions of interglycosidic linkages were established by the ROESY and HMBC spectra of 3 (Table 2) where the cross-peaks between H-1 Xyl1 and H-3 (C-3) of an aglycone, H-1 Qui2 and H-2 (C-2) Xyl1; H-1 Glc3 and H-4 (C-4) Qui2; H-1 MeGlc4 and H-3 Glc3; H-1 Glc5 and H-4 Xyl1; H-1 MeGlc6 and H-3 (C-3) Glc5 were observed.
The signals of C-6 MeGlc4 and C-6 Glc5 in the 13C NMR spectrum of 3 were observed at δC 67.0 and δC 67.1, correspondingly, due to α-shifting effects of the sulfate groups at these positions. Thus, the hexasaccharide disulfated chain of kuriloside G (3) was first found in the sea cucumber glycosides. The NMR spectra of the aglycone part of 3 coincided with that of kuriloside A3 (1), indicating the identity of these aglycones (Table S2).
The (−)ESI-MS/MS of 3 demonstrated the fragmentation of [M2Na − Na] ion at m/z 1509.5. The peaks of fragment ions were observed at m/z 1389.6 [M2Na – Na − NaHSO4], 1333.5 [M2Na – Na − C7H12O5(MeGlc)], 1231.5 [M2Na – Na − C7H11O8SNa(MeGlcSO3Na)], 1069.4 [M2Na – Na − C7H11O8SNa(MeGlcSO3Na) − C6H10O5(Glc)], 923.4 [M2Na – Na − C7H11O8SNa(MeGlcSO3Na) − C6H10O5(Glc)] − C6H10O4(Qui)].
All these data indicate that kuriloside G (3) is 3β-O-{6-O-sodium sulfate-3-O-methyl-β-d-glucopyranosyl-(1→3)-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16α-hydroxy,20-oxo-lanost-9(11)-ene.
The molecular formula of kuriloside H (4) was determined to be C64H101O42S3Na3 from the [M3Na − Na] ion peak at m/z 1683.4701 (calc. 1683.4730), [M3Na − 2Na]2 ion peak at m/z 830.2425 (calc. 830.2419), and [M3Na − 3Na]3 ion peak at m/z 545.8332 (calc. 545.8315) in the (−)HR-ESI-MS. The presence of three-charged ions in the (−)HR-ESI-MS of kuriloside H (4) was indicative for the trisulfated glycoside.
The 1H and 13C NMR spectra corresponding to the carbohydrate chain of kuriloside H (4) (Table 3) demonstrated six signals of anomeric protons at δH 4.63–5.21 (d, J = 7.1–8.6 Hz) and the signals of anomeric carbons at δC 102.8–104.7 deduced by the HSQC spectrum, indicative of hexasaccharide moiety with β-glycosidic bonds. The signals of each sugar residue were assigned by the analysis of the 1H,1H-COSY, 1D TOCSY, ROESY, and HSQC spectra, enabling the identification of monosaccharide units in the chain of 4 as one xylose (Xyl1), one quinovose (Qui2), three glucoses (Glc3, Glc4 and Glc5), and one 3-O-methylglucose (MeGlc6). Therefore, the monosaccharide composition of 4 was the same as in kuriloside D1 (2).
However, in the 13C NMR spectrum of 4 three signals at δC 67.6 (C-6 Glc3), 67.4 (C-6 Glc5), and 67.0 (C-6 MeGlc6), characteristic for sulfated by C-6 hexose units, were observed instead of one signal at δC 67.0 (C-6 Glc5) in the spectrum of 2. The signal of the OMe-group observed at δC 60.4 indicated one terminal monosaccharide residue was methylated. Actually, the protons of the OMe-group (δH 3.75, s) correlated in the HMBC spectrum with C-3 MeGlc6 (δC 86.1), which was, in turn, attached to C-3 Glc5 (ROE-correlation H-1 MeGlc6 (δH 5.13 (d, J = 7.4 Hz)/H-3 Glc5 (δH 4.13 (t, J = 8.6 Hz)). At the same time, the fourth (another terminal) monosaccharide unit was glucose (the signal of C-3 Glc4 was shielded to δC 77.7 due to the absence of O-methylation). The positions of all interglycosidic linkages were elucidated based on the ROESY and HMBC correlations (Table 3).
Hence, kuriloside H (4) has a hexasaccharide chain with a non-methylated terminal Glc4 residue and three sulfate groups. This carbohydrate chain is first found in the glycosides of the sea cucumbers and kuriloside H (4) is the most polar glycoside discovered so far as well as two tetrasulfated pentaosides isolated from Psolus fabricii [20].
The analysis of the 13C NMR spectrum of the aglycone part of 4 demonstrated its identity to the aglycone of kurilosides A1 and C1, isolated earlier [19]. Therefore, kuriloside H (4) contains a 22,23,24,25,26,27-hexa-nor-lanostane aglycone with 9(11)-double bond and acetoxy-groups at C-16 and C-20. β-orientation of the acetoxy group at C-16 and (20S)-configuration were established on the base of coincidence of the coupling constants (J16/17 = 7.7 Hz and J17/20 = 10.6 Hz), observed in the 1H NMR spectra of 4 and kuriloside A1, and confirmed by the ROE-correlation H-16/H-32 in the spectrum of 4 (Table S4).
The (−)ESI-MS/MS of kuriloside H (4) demonstrated the fragmentation of the [M3Na − Na] ion at m/z 1683.5. The peaks of fragment ions were observed at m/z 1503.5 [M3Na – Na − CH3COOH − NaHSO4], 1443.5 [M3Na – Na − 2CH3COOH − NaHSO4], 1281.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C6H10O5(Glc)], 1165.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C7H11O8SNa(MeGlcOSO3)], and 1003.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C7H11O8SNa(MeGlcOSO3) − C6H10O5(Glc)], corroborating its carbohydrate chain structure.
All these data indicate that kuriloside H (4) is 3β-O-{β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[6-O-sodium sulfate-3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β,(20S)-diacetoxy-lanost-9(11)-ene.
The molecular formula of kuriloside I (5) was determined to be C54H87O35S3Na3 from the [M3Na − Na] ion peak at m/z 1437.3952 (calc. 1437.3991), [M3Na − 2Na]2− ion peak at m/z 707.2049 (calc. 707.2049), and [M3Na − 3Na]3− ion peak at m/z 463.8076 (calc. 463.8069) in the (−)HR-ESI-MS, indicating the presence of three sulfate groups. The 1H and 13C NMR spectra corresponding to the carbohydrate part of kuriloside I (5) (Table 4) demonstrated five characteristic doublets at δH 4.63–5.13 (d, J = 6.6–7.8 Hz) and corresponding signals of anomeric carbons at δC 102.4–104.7 deduced by the HSQC spectrum, which indicated the presence of five monosaccharide residues in the carbohydrate chain of 5. The signals at δC 67.0, 67.6, and 67.7 indicated the presence of three sulfate groups as in the carbohydrate chain of kuriloside H (4). Indeed, the comparison of the 13C NMR spectra of kurilosides I (5) and H (4) showed that they differed by the absence in the spectrum of 5 of the signals corresponding to non-sulfated terminal glucose residue attached to C-3 Glc3 in the carbohydrate chain of 4. The signal of C-3 Glc3 in the 13C NMR spectrum of 5 was observed at δC 76.9 (instead of δC 86.3 in the spectrum of 4), demonstrating the absence of a glycosylation effect. The presence of xylose (Xyl1), quinovose (Qui2), two glucose (Glc3, Glc4), and one 3-O-methylglucose (MeGlc5) residue was deduced from the analysis of the 1H,1H-COSY, HSQC and 1D TOCSY spectra of 5. The positions of interglycosidic linkages were elucidated based on the ROESY and HMBC correlations (Table 4) and indicated the presence of the branched at the C-4 Xyl1 pentasaccharide chain in 5, with the same architecture as in the other pentaosides of T. kurilensis. Thus, kuriloside I (5) contains a new pentasaccharide branched trisulfated chain.
The analysis of the 13C and 1H NMR spectra of the aglycone part of 5 indicated the presence of 22,23,24,25,26,27-hexa-nor-lanostane aglycone having a 9(11)-double bond (Table 5). The signals of methine group CH-16 were observed at c δC 72.8 (C-16) and at δH 4.82 (dd, J = 7.1; 14.9 Hz, H-16) due to the attachment of the hydroxyl group to this position. The HMBC correlations H-15/C-16 and H-20/C-16 confirmed this. The signals of C-20 and H-20 were shielded to δC 66.5 and δH 4.38 (dd, J = 6.0; 9.5 Hz), correspondingly, when compared with the same signals in the spectra of kuriloside H (4) (δC-20 69.4, δH-20 5.46 (dd, J = 6.1; 10.6 Hz)), containing (20S)-acetoxy-group. Hence, it was supposed that the attachment of the hydroxyl group to C-20 was in the aglycone of kuriloside I (5) instead of the acetoxy group in the aglycone of kuriloside H (4).
The ROE-correlations H-16/H-17 and H-16/H-32 indicated a 16β-OH orientation in the aglycone of kuriloside I (5). (20S)-configuration in 5 was determined on the base of the closeness of the coupling constant J20/17 = 9.5 Hz to those in the spectra of kurilosides A1, C1 [19], and H (4) and corroborated by the observed ROE-correlations H-17/H-21, H-20/H-18 and biogenetic background. Hence, kuriloside I (5) has an aglycone with a 16β,(20S)-dihydroxy-fragment that is unique in marine glycosides.
The (−)ESI-MS/MS of kuriloside I (5) demonstrated the fragmentation of the [M3Na − Na] ion at m/z 1437.5. The peaks of fragment ions were observed at m/z 1317.4 [M3Na – Na − NaHSO4], 1197.4 [M3Na – Na − 2NaHSO4], 1173.4 [M3Na − Na − C6H9O8SNa(GlcOSO3)], 1039.4 [M3Na – Na − NaHSO4 − C7H11O8SNa(MeGlcOSO3)], 1027.3 [M3Na – Na − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui)], 907.3 [M3Na – Na − NaHSO4 − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui)], 895.4 [M3Na – Na − C6H9O8SNa(GlcOSO3) − C7H11O8SNa(MeGlcOSO3)], 667.4 [M3Na – Na − C24H39O2(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − H], 519.0 [M3Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − H], and 417.1 [M3Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − NaHSO3], corroborating the structure of the glycoside.
All these data indicate that kuriloside I (5) is 3β-O-{6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[6-O-sodium sulfate-3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β,(20S)-dihydroxy-lanost-9(11)-ene.
The molecular formula of kuriloside I1 (6) was determined to be C58H91O37S3Na3 from the [M3Na − 2Na]2− ion peak at m/z 749.2148 (calc. 747.2155) and [M3Na − 3Na]3− ion peak at m/z 491.8146 (calc. 491.8139) in the (−)HR-ESI-MS. Kuriloside I1 (6) as well as kuriloside I (5) belong to one group because they have identical trisulfated pentasaccharide chains and, therefore, parts of the 1H and 13C NMR spectra corresponding to the carbohydrate chains are coincident (Table 4). 22,23,24,25,26,27-hexa-nor-lanostane aglycone of kuriloside I1 (6) is identical to that of kurilosides H (4), A1 and C1 [19] (Table S4) and characterized by the presence of 16β,(20S)-diacetoxy-fragment.
The (−)ESI-MS/MS of 6 demonstrated the fragmentation of the [M3Na − Na] ion at m/z 1521.4 and [M3Na − 2Na]2− ion at m/z 749.2. The peaks of fragment ions were observed at m/z: 1281.4 [M3Na – Na − 2CH3COOH − NaHSO4], 1197.4 [M3Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3)], 1137.4 [M3Na – Na − 2CH3COOH − C6H9O8SNa(GlcOSO3)], 859.4 [M3Na – Na − 2CH3COOH − C6H9O8SNa(GlcOSO3) − C7H11O8SNa(MeGlcOSO3)], 719.2 [M3Na − 2Na − CH3COOH]2−, 629.2 [M3Na − 2Na − NaHSO4]2−, and 557.2 [M3Na − 2Na − 2CH3COOH − C6H9O8SNa(GlcOSO3)]2−, which confirmed its structure, established by the NMR data.
All these data indicate that kuriloside I1 (6) is 3β-O-{6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[6-O-sodium sulfate-3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β,(20S)-diacetoxy-lanost-9(11)-ene.
The molecular formula of kuriloside J (7) was determined to be C56H90O33S2Na2 from the [M2Na−Na] ion peak at m/z 1377.4687 (calc. 1377.4709) and [M2Na−2Na]2− ion peak at m/z 677.2413 (calc. 677.2408) in the (−)HR-ESI-MS. In the 1H and 13C NMR spectra of the carbohydrate part of kuriloside J (7) (Table 6), five signals of anomeric protons at δH 4.65–5.12 (d, J = 7.2–7.9 Hz) and corresponding five signals of anomeric carbons at δC 102.0–104.7, deduced by the HSQC spectrum, were observed, which indicated the presence of a pentasaccharide chain similar to compounds 5 and 6. Actually, the comparison of the 13C NMR spectra of sugar parts of kurilosides I (5) and J (7) revealed the closeness of the signals of four monosaccharide residues, except the signals of the third unit, attached to C-4 Qui2. The analysis of the signals of this residue in the 1H,1H-COSY, HSQC, 1D TOCSY, and ROESY spectra of kuriloside J (7) showed that it is a glucose without a sulfate group (δC-6 Glc3 61.8, δC-5 Glc3 77.7), while in the carbohydrate chain of 5, this residue is sulfated. The other sulfate groups occupy the same positions at C-6 Glc4 (δC-6 Glc4 67.1, δC-5 Glc4 75.1) and at C-6 MeGlc5 (δC-6 MeGlc5 66.7, δC-5 MeGlc5 75.5) as in the sugar chains of kurilosides I (5) and I1 (6). The positions of interglycosidic linkages in the carbohydrate chain of 7, elucidated by the ROESY and HMBC correlations (Table 6), were the same as in kurilosides of groups A [19] and I. Thus, kuriloside J (7) is a branched disulfated pentaoside with the sulfate groups bonding to C-6 Glc4 and C-6 MeGlc5 in the upper semi-chain.
The analysis of the 1H and 13C NMR spectra of the aglycone part of kuriloside J (7) (Table 7) revealed the presence of the hexa-nor-lanostane aglycone having a 9(11)-double bond, similar to the majority of the other glycosides of T. kurilensis [19]. The signals at δC 171.2 and 21.1 were characteristic for the acetoxy group, bonded to C-16, that was deduced from the characteristic δC 75.1 value of C-16 and the ROE-correlation between the signal of O-acetyl methyl group (δH 2.17 (s)) and H-16 (δH 5.76 (m). Actually, in the spectrum of 7, the signal of C-16 was deshielded by 2.3 ppm due to the presence of the acetoxy-group when compared with the corresponding signal in the spectrum of kuriloside I (5), having a 16-hydroxy-group. The presence of hydroxyl group at C-20 was deduced from the characteristic signals at δC 64.8 (C-20) and δH 4.28 (dd, J = 6.4; 10.0 Hz, H-20). Hence, the hydroxyl group is attached to C-20 in the aglycones of kuriloside I (5) and J (7). The ROE-correlation H-16/H-32 indicated 16β-O-Ac orientation in the aglycone of kuriloside J (7), which was confirmed by the coupling constant J16/17 = 7.9 Hz, indicating both protons, H-16 and H-17, to be α [21]. (20S)-configuration in 7 was corroborated by the coupling constant J17/20 = 10.0 Hz and the ROE-correlations H-17/H-21, H-20/H-18. Hence, kuriloside J (7) is characterized by the new hexa-nor-lanostane aglycone with a 16β-acetoxy,(20S)-hydroxy-fragment.
The (−)ESI-MS/MS of kuriloside J (7) demonstrated the fragmentation of [M2Na − Na] ion at m/z 1377.5. The peaks of fragment ions were observed at m/z 1317.4 [M2Na – Na − CH3COOH], 1257.4 [M2Na – Na − NaHSO4], 1197.5 [M2Na – Na − CH3COOH − NaHSO4], 1155.4 [M2Na – Na − CH3COOH − C6H10O5 (Glc)], 1039.4 [M2Na – Na − CH3COOH − C7H11O8SNa(MeGlcOSO3)], 1009.4 [M2Na – Na − CH3COOH − C6H10O5(Glc) − C6H10O4(Qui)], 889.4 [M2Na − Na − NaHSO4 − CH3COOH − C6H10O5(Glc) − C6H10O4(Qui)], 667.4 [M2Na – Na − C26H41O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − H], 519.0 [M2Na – Na − C26H41O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 417.1 [M2Na – Na − C26H41O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − NaHSO3], corroborating the structure of its aglycone and the carbohydrate chain.
All these data indicate that kuriloside J (7) is 3β-O-{β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[6-O-sodium sulfate-3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β-acetoxy,(20S)-hydroxy-lanost-9(11)-ene.
The molecular formula of kuriloside K (8) was determined to be C54H88O32S2Na2 from the [M2Na − Na] ion peak at m/z 1335.4573 (calc. 1335.4603) and the [M2Na − 2Na]2− ion peak at m/z 656.2357 (calc. 656.2356) in the (−)HR-ESI-MS. In the 1H and 13C NMR spectra of the carbohydrate part of kuriloside K (8) (Table 8), five signals of anomeric protons at δH 4.62–5.19 (d, J = 6.5–8.5 Hz) and five signals of anomeric carbons at δC 102.7–104.8, deduced by the HSQC spectrum, were indicative for the pentasaccharide chain with the β-configuration of glycosidic bonds. The comparison of the 13C NMR spectra of oligosaccharide parts of trisulfated kuriloside I (5) and kuriloside K (8) revealed the coincidence of the monosaccharide residues, except for the signals of a terminal, 3-O-methylglucose (MeGlc5) unit. The analysis of the signals of this residue in the 1H,1H-COSY, HSQC, 1D TOCSY, and ROESY spectra of kuriloside K (8) showed the absence of a sulfate group (δC-6 MeGlc5 61.6, δC-5 MeGlc5 77.5), in contrast with the carbohydrate chain of 5C-6 MeGlc5 67.0, δC-5 MeGlc5 75.4). The positions of interglycosidic linkages in the carbohydrate chain of 8, deduced by the ROESY and HMBC correlations (Table 8), showed that kuriloside K (8) has branching at C-4 Xyl1 in the disulfated pentasaccharide chain with the sulfate groups at C-6 Glc3 and C-6 Glc4.
The NMR spectra as well as the ROE-correlations of the aglycone part of kuriloside K (8) were coincident to that of kuriloside I (5), indicating the presence of a 22,23,24,25,26,27-hexa-nor-lanostane aglycone with 16β,(20S)-dihydroxy-fragment (Table 5).
The (−)ESI-MS/MS of 8 demonstrated the fragmentation of the [M2Na − Na] ion at m/z 1335.4 resulted in the fragment ions observed at m/z: 1215.4 [M2Na – Na − NaHSO4], 1159.4 [M2Na – Na − C7H12O5(MeGlc)], 1071.4 [M2Na – Na − C6H9O8SNa(GlcOSO3)], 925.4 [M2Na – Na − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui)], 895.4 [M2Na – Na − C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc)], 713.3 [M2Na – Na − C24H39O2(Agl) − C6H9O8SNa(GlcOSO3) − H], 417.1 [M2Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [M2Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − C7H12O5(MeGlc) − H], which confirmed the chemical structure established by the NMR data.
All these data indicate that kuriloside K (8) is 3β-O-{6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β,(20S)-dihydroxy-lanost-9(11)-ene.
The molecular formula of kuriloside K1 (9) was determined to be C56H90O33S2Na2 from the [M2Na − Na] ion peak at m/z 1377.4723 (calc. 1377.4709) and the [M2Na − 2Na]2− ion peak at m/z 677.2426 (calc. 677.2408) in the (−)HR-ESI-MS. The comparison of the 1H and 13C NMR spectra of the carbohydrate chains of kuriloside K1 (9) and kuriloside K (8) demonstrated their coincidence (Table 8) due to the presence of the same pentasaccharide, branched by C-4 Xyl1, sugar parts with the sulfate groups at C-6 Glc3 and C-6 Glc4. The analysis of the NMR spectra of the aglycone part of 9 indicated the presence of 22,23,24,25,26,27-hexa-nor-lanostane aglycone with 16β-acetoxy,(20S)-hydroxy-fragment (Table 7), identical to that of kuriloside J (7). Hence, kuriloside K1 (9) is an isomer of kuriloside J (7) by the position of one of the sulfate groups, that was confirmed by the presence of the ion-peaks having coincident m/z values in their (−)ESI-MS/MS spectra.
The (−)ESI-MS/MS of 9 demonstrated the fragmentation of [M2Na − Na] ion at m/z 1377.5. The peaks of fragment ions were observed at m/z 1317.4 [M2Na – Na − CH3COOH], 1197.5 [M2Na – Na − CH3COOH − NaHSO4], 1069.5 [M2Na – Na − C6H10O5(Glc)], 1053.4 [M2Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3)], 877.4 [M2Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc)], 731.3 [M2Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc) − C6H10O4(Qui)], 565.1 [M2Na – Na − C26H41O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − H], 417.1 [M2Na – Na − C26H41O4(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl)].
All these data indicate that kuriloside K1 (9) is 3β-O-{6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)-β-d-quinovopyranosyl-(1→2)-[3-O-methyl-β-d-glucopyranosyl-(1→3)-6-O-sodium sulfate-β-d-glucopyranosyl-(1→4)]-β-d-xylopyranosyl}-22,23,24,25,26,27-hexa-nor-16β-acetoxy,(20S)-hydroxy-lanost-9(11)-ene.
When the studies on the glycosides of T. kurilensis were started [22], the complexity of glycosidic mixture became obvious. Therefore, the part of the glycosidic sum was subjected to solvolytic desulfation to facilitate the chromatographic separation and isolation of the glycosides. However, the obtained fraction of desulfated glycosides was separated only recently as part of the effort to discover some minor glycosides possessing interesting structural peculiarities. As a result, the compounds 10 and 11 were isolated (Figure 2). Their structures were elucidated by thorough analysis of 1D and 2D NMR spectra, similar to the natural compounds 19 and confirmed by the HR-ESI-MS.
The molecular formula of DS-kuriloside L (10) was determined to be C41H64O15 from the [M − H] ion peak at m/z 795.4169 (calc. 795.4172) in the (−)HR-ESI-MS. Compound 10 has a trisaccharide sugar chain (for NMR data see Tables S5 and S6, for original spectra see Figures S69–S76) and a hexa-nor-lanostane-type aglycone identical to that of kuriloside A2 [19].
The molecular formula of DS-kuriloside M (11) was determined to be C54H88O26 from the [M − H] ion peak at m/z 1151.5469 (calc. 1151.5491) in the (−)HR-ESI-MS. DS-kuriloside M (11), characterized by the 7(8)-double bond in the hexa-nor-lanostane nucleus and pentasaccharide chain, differed from the chains of kurilosides of the groups A, I, J, and K by the absence of sulfate groups (see Tables S7 and S8 for the NMR data, Figures S77–S85 for the original spectra). Noticeably, all of the isolated kurilosides, with the exception of 11, contained a 9(11)-double bond in the polycyclic systems.

2.2. Bioactivity of the Glycosides

Cytotoxic activities of compounds 19 against mouse neuroblastoma Neuro 2a, normal epithelial JB-6 cells, and erythrocytes were studied (Table 9). Known earlier cladoloside C was used as a positive control because it demonstrated a strong hemolytic effect [23]. Erythrocytes are an appropriate model for the studying of structure–activity relationships of the glycosides, since, despite many of them demonstrate hemolytic activity, the effect strongly depends on the structure of the compound. Normal epithelial JB-6 cells were used to search the compounds, not cytotoxic against this cell line, but having selective activity against other cells. Triterpene glycosides of sea cucumbers are known modulators of P2X receptors of immunocompetent cells when acting in nanomolar concentrations [24]. Neuroblastoma Neuro 2a cells are convenient model for the study of agonists/antagonists of P2X receptors—the targets in the treatment of selected nervous system diseases. Therefore, the activators, modulators, and blockers of purinergic receptors are of great interest [4] and the compounds demonstrating high cytotoxicity against Neuro 2a cells could be more deeply studied with the models of neurodegenerative diseases.
Kuriloside H (4), having a hexasaccharide trisulfated chain and the aglycone with acetoxy-groups at C(16) and C(20), was the most active compound in the series, demonstrating strong cytotoxicity against erythrocytes and JB-6 cells and a moderate effect against Neuro 2a cells. Kuriloside I1 (6), differing from 4 by the lack of a terminal glucose residue in the bottom semi-chain, was slightly less active. The effect of this glycoside is obviously explained by the presence of the acetoxy-group at C(20) in their aglycones, which compensates for the absence of a side chain, essential for the demonstration of the membranolytic action of the glycosides. Kurilosides J (7) and K1 (9), differing by the position of the second sulfate group attached to C(6) of different terminal monosaccharide residues, but having the same aglycones with 16β-acetoxy-group, were moderately cytotoxic against erythrocytes and JB-6 cells and had no any effect against Neuro 2a cells. However, the presence of the hydroxyl group in this position causes the loss of activity, so, the rest of compounds 13, 5, and 8 were not cytotoxic.

2.3. Biosynthetic Pathways of the Glycosides

The analysis of the structural peculiarities of the aglycones and carbohydrate chains of all the glycosides (kurilosides) found in the sea cucumber T. kurilensis allowed us to construct the metabolic network based on their biogenetic relationships. As a result, some biosynthetic pathways are taking shape (Figure 3).
Since the triterpene glycosides of sea cucumbers are the products of a mosaic type of biosynthesis [17], the carbohydrate chains and the aglycones are biosynthesized independently of each other. The main biosynthetic transformations of sugar parts of kurilosides are glycosylation and several rounds of sulfation that can be shifted in time relatively to each other (Figure 3). This has led to the formation of the set of compounds having 11 different oligosaccharide fragments. Meanwhile, there are some missing links (biosynthetic intermediates) in these biogenetic rows: biosides consisted of the glucose bonded to the xylose by β-(1→4)-glycosidic linkage, then triosides and tetraosides having glucose bonded to C(2) Xyl1—the precursors on kuriloside E, two types of disulfated hexaosides with a non-methylated terminal Glc4 unit that should biosynthetically appear between the carbohydrate chains of kurilosides of groups D and H; J and H; K and H, which have not so far been isolated. DS-kuriloside L (10) with a trisaccharide sugar chain is perfectly fit into the network as one of the initial stages of biosynthesis, illustrating the stepwise glycosylation of the synthesized chain. The structure of its sugar chain as well as the chain of kuriloside C1 [19] suggests the glycosylation of C(4) Xyl1 and initialization of the growth of the upper semi-chain precedes the glycosylation of C(2) Xyl1. There are some branchpoints of the biosynthetic pathways where the processes of sulfation and glycosylation or sulfation and methylation are alternative/concurrent. The final product of such transformations is the trisulfated hexaoside kuriloside H (4), the most biologically active compound in the series (Table 9), which can be formed by different pathways, and is a characteristic feature of a mosaic type of biosynthesis. However, this glycoside is minor (0.9 mg) in the glycosidic sum of T. kurilensis, while the main compounds are kurilosides of group A (~150 mg), and these carbohydrate chains can be considered as the most actively metabolized and resulted in the formation of at least three different types of sugar chains (kurilosides of the groups D, J, and K). Thus, their formation is a mainstream of the biosynthesis of carbohydrate chains of the glycosides of T. kurilensis.
As for the directions of biosynthesis of the aglycone parts of kurilosides (Figure 4), the scheme presented earlier [19] was complemented by some structures found recently, representing intermediate biosynthetic stages. DS-kuriloside M (11) is the only glycoside from T. kurilensis characterized by the 7(8)-double bond in the lanostane nucleus, when all the other kurilosides contain a 9(11)-double bond in the polycyclic systems. This finding indicates the existence of two oxidosqualene cyclases (OSCs)—enzymes converted 2,3-oxidosqualene into different triterpene alcohols giving rise various skeletons of the aglycones—in this species of sea cucumbers. These data are in good agreement with the results of the investigations of the genes coding OSCs in the other species of the sea cucumbers—Eupentacta fraudatrix [25], Stichopus horrens [26], and Apostichopus japonicus [27], demonstrating that even when the glycosides preferably contain the aglycones with one certain position of intra-nucleus double bond (Δ7(8)-aglycones in E. fraudatrix [13,18] and S. horrens [28,29], and Δ9(11)-aglycones in A. japonicus [30,31]), the genes of at least two OSCs, producing aglycone precursors with different double bond positions, are expressed, albeit with different efficiency.
The constituent hexa-nor-lanostane aglycones of kurilosides are biosynthesized via the oxidative cleavage of the side chain from the precursors having normal side chains (for example, kurilosides D [19] and D1 (2)) and oxygen-containing substituents at C-20 and C-22 (Figure 4). As result, the aglycone of kuriloside E [19] was formed. The subsequent biosynthetic transformations of the aglycones can occur in two directions. The first one started from the reduction of the C-20-oxo-group to the hydroxy-group, followed by the oxidation of C-16 to the hydroxy-group with the formation of the aglycones of kurilosides I (5) and K (8). It is important that the latter reaction is carried out by the cytochrome P450 monooxygenase selectively bonding to the β-hydroxy-group to C-16 in the derivatives containing the hydroxy-group at C-20. The next steps lead to the acetylation of hydroxyl group at C-16 (as in the aglycones of kurilosides J (7) and K1 (9)) followed by the acetylation of the hydroxyl group at C-20 (the aglycones of kurilosides A1, C1, H (4), and I1 (6) correspond to this conversion). Obviously, the oxidation of C-16 precedes the acetylation of C-20 since no aglycones with a 16-hydroxy,20-acetoxy-fragment have been found.
The second direction of the aglycone biosynthesis occurs through the introduction of the α-hydroxyl group to C-16, resulting in the formation of aglycone of kurilosides A3 (1), G (3), and F [19]. Moreover, the transformation leading to hexa-nor-lanostane aglycones having a 16α-hydroxy,20-oxo-fragment is the same in the biosynthetic precursors with 7(8)- and 9(11)-double bonds, which is confirmed by the aglycone structure of 11. Subsequent acetylation of the 16α-OH-group leads to the aglycone of kuriloside A, while intramolecular dehydration to the aglycone of kuriloside A2 and DS-kuriloside L (10). Therefore, an α-hydroxy-group was selectively introduced to C-16 of the 20-oxo-lanostane precursors.

3. Materials and Methods

3.1. General Experimental Procedures

Specific rotation, Perkin-Elmer 343 Polarimeter (Perkin-Elmer, Waltham, MA, USA); NMR, Bruker Avance III 700 Bruker FT-NMR (Bruker BioSpin GmbH, Rheinstetten, Germany) (700.00/176.03 MHz) (1H/13C) spectrometer; ESI MS (positive and negative ion modes), Agilent 6510 Q-TOF apparatus (Agilent Technology, Santa Clara, CA, USA), sample concentration 0.01 mg/mL; HPLC, Agilent 1260 Infinity II with a differential refractometer (Agilent Technology, Santa Clara, CA, USA); column Phenomenex Synergi Fusion RP (10 × 250 mm, 5 μm) (Phenomenex, Torrance, CA, USA).

3.2. Animals and Cells

Specimens of the sea cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin) (family Cucumariidae; order Dendrochirotida) were collected in August 1990 using an industrial rake-type dredge in the waters of Onekotan Island (Kurile Islands, the Sea of Okhotsk) at a depth of 100 m by the medium fishing refrigerator trawler “Breeze” with a rear scheme of trawling during scallop harvesting. The sea cucumbers were identified by Prof. V.S. Levin; voucher specimens are preserved at the A.V. Zhirmunsky National Scientific Center of Marine Biology, Vladivostok, Russia.
CD-1 mice, weighing 18–20 g, were purchased from RAMS ‘Stolbovaya’ nursery (Stolbovaya, Moscow District, Russia) and kept at the animal facility in standard conditions. All experiments were performed following the protocol for animal study approved by the Ethics Committee of the Pacific Institute of Bioorganic Chemistry No. 0085.19.10.2020. All experiments were conducted in compliance with all of the rules and international recommendations of the European Convention for the Protection of Vertebrate Animals Used for Experimental Studies.
Mouse epithelial JB-6 cells Cl 41-5a and mouse neuroblastoma cell line Neuro 2a (ATCC ® CCL-131) were purchased from ATCC (Manassas, VA, USA).

3.3. Extraction and Isolation

The extract of the glycosides, obtained by the standard procedure, and the initial stages of their separation were discussed in a previous paper [19]. As result of the chromatography on Si gel columns using CHCl3/EtOH/H2O (100:125:25) as the mobile phase, the fractions II–V were obtained, which were subjected to HPLC on a Phenomenex Synergi Fusion RP (10 × 250 mm) column. The separation of fraction II with MeOH/H2O/NH4OAc (1 M water solution) (63/35/2) as the mobile phase resulted in the isolation of individual kuriloside A3 (1) (79.2 mg). HPLC of fraction III with MeOH/H2O/NH4OAc (1 M water solution) (60/38/2) as the mobile phase gave 3.1 mg of kuriloside K1 (9) and 0.9 mg of kuriloside K (8). Fraction IV was the result of the HPLC using MeOH/H2O/NH4OAc (1 M water solution) (68/31/1) as the mobile phase was separated to the subfractions 1–7. Further rechromatography of subfraction 7 with MeOH/H2O/NH4OAc (1 M water solution) (63/34/3) followed by (60/37/3) as the mobile phases gave 3.1 mg of kuriloside I1 (6). The use of the ratio of MeOH/H2O/NH4OAc (1 M water solution) (62/35/3) for subfraction 4 gave 2.3 mg of kuriloside J (7) and the ratio (58/39/3) for subfraction 3 gave 7 mg of kuriloside D1 (2). For the HPLC of the most polar fraction V, obtained after Si gel chromatography, the ratio of the same solvents (60/39/1) was applied, which led to the isolation of 10 subfractions. Some of them were minor, thus only the main ones were submitted for further separation. For subfraction 10, the ratio (64/34/2) was applied to give 0.9 mg of kuriloside H (4). The ratio (54/43/3) used for HPLC of subfraction 4 gave 1.9 mg of kuriloside G (3) and 2.3 mg of kuriloside I (5).
The fraction of desulfated derivatives obtained earlier by the standard methodology (~350 mg) was submitted to column chromatography on Si gel using CHCl3/EtOH/H2O (100:50:4) and CHCl3/MeOH/H2O (250:75:3) as mobile phases to give subfractions DS-1−DS-8, which were subsequently subjected to HPLC on the same column as compounds 19. Individual DS-kuriloside M (11) (3.8 mg) was isolated as a result of separating the subfraction DS-6 with 66% MeOH as the mobile phase which gave several fractions, followed by the HPLC of one of them with 32% CH3CN as the mobile phase. HPLC of subfraction DS-2 with 50% CH3CN as the mobile phase, followed by 46% CH3CN as the mobile phase, gave 4.0 mg of DS-kuriloside L (10).

3.3.1. Kuriloside A3 (1)

Colorless powder; [ α ] D 20 −1° (c 0.1, 50% MeOH). NMR: See Tables S1 and S2, Figures S1–S6. (−)HR-ESI-MS m/z: 1231.5063 (calc. 1231.5059) [MNa − Na]; (−)ESI-MS/MS m/z: 1069.5 [MNa – Na − C6H10O5(Glc)], 1055.4 [MNa − Na–C7H12O5(MeGlc)], 923.4 [MNa − Na–C6H10O5(Glc) − C6H10O4(Qui)], 747.3 [MNa − Na–C6H10O5(Glc) − C6H10O4(Qui) − C7H12O5(MeGlc)], 695.1 [MNa – Na − C24H37O3(Agl) − C6H10O5(Glc) − H], 565.1 [MNa − Na–C24H37O2(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − H], 549.1 [MNa − Na–C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − H], 417.1 [MNa − Na–C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [MNa − Na–C24H37O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) – C7H12O5(MeGlc) − H].

3.3.2. Kuriloside D1 (2)

Colorless powder; [ α ] D 20 –39° (c 0.1, 50% MeOH). NMR: See Table 1 and Table S3, Figures S7–S13. (−)HR-ESI-MS m/z: 1507.6291 (calc. 1507.6268) [MNa − Na]; (−)ESI-MS/MS m/z: 1349.5 [MNa – Na − C8H15O3 + H], 1187.5 [MNa – Na − C8H15O3 −C6H10O5(Glc) + H], 1025.4 [MNa – Na − C8H15O3 − C6H10O5(Glc) − C6H10O5(Glc) + H], 879.4 [MNa – Na − C8H15O3 −C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) + H], 565.1 [MNa – Na − C30H47O4(Agl) − C6H10O5(Glc) − C6H10O5(Glc) −C6H10O4(Qui) − H], 417.1 [MNa – Na − C30H47O5(Agl) − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [MNa – Na − C30H47O5(Agl) − C6H10O5(Glc) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − C7H12O5(MeGlc) − H].

3.3.3. Kuriloside G (3)

Colorless powder; [ α ] D 20 −2° (c 0.1, 50% MeOH). NMR: See Table 2 and Table S2, Figures S14–S22. (−)HR-ESI-MS m/z: 1509.5102 (calc. 1509.5132) [M2Na − Na]; 743.2624 (calc. 743.2626) [M2Na − 2Na]2−, (−)ESI-MS/MS m/z: 1389.6 [M2Na – Na − NaHSO4], 1333.5 [M2Na – Na − C7H12O5(MeGlc)], 1231.5 [M2Na – Na − C7H11O8SNa(MeGlcSO3Na)], 1069.4 [M2Na – Na − C7H11O8SNa(MeGlcSO3Na) − C6H10O5(Glc)], 923.4 [M2Na –Na − C7H11O8SNa(MeGlcSO3Na) − C6H10O5(Glc)] − C6H10O4(Qui)].

3.3.4. Kuriloside H (4)

Colorless powder; [ α ] D 20 −3° (c 0.1, 50% MeOH). NMR: See Table 3 and Table S4, Figures S23–S31. (−)HR-ESI-MS m/z: 1683.4701 (calc. 1683.4730) [M3Na − Na], 830.2425 (calc. 830.2419) [M3Na − 2Na]2, 545.8332 (calc. 545.8315) [M3Na − 3Na]3; (−)ESI-MS/MS m/z: 1503.5 [M3Na – Na − CH3COOH − NaHSO4], 1443.5 [M3Na – Na − 2CH3COOH − NaHSO4], 1281.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C6H10O5(Glc)], 1165.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C7H11O8SNa(MeGlcOSO3)], 1003.4 [M3Na – Na − 2CH3COOH − NaHSO4 − C7H11O8SNa(MeGlcOSO3) − C6H10O5 (Glc)].

3.3.5. Kuriloside I (5)

Colorless powder; [ α ] D 20 −9° (c 0.1, 50% MeOH). NMR: See Table 4 and Table 5, Figures S32–S40. (−)HR-ESI-MS m/z: 1437.3952 (calc. 1437.3991) [M3Na − Na], 707.2049 (calc. 707.2049) [M3Na − 2Na]2, 463.8076 (calc. 463.8069) [M3Na − 3Na]3; (−)ESI-MS/MS m/z: 1317.4 [M3Na – Na − NaHSO4], 1197.4 [M3Na – Na − 2NaHSO4], 1173.4 [M3Na – Na − C6H9O8SNa(GlcOSO3)], 1039.4 [M3Na – Na − NaHSO4 − C7H11O8SNa(MeGlcOSO3)], 1027.3 [M3Na – Na − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui)], 907.3 [M3Na – Na − NaHSO4 − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui)], 895.4 [M3Na – Na − C6H9O8SNa(GlcOSO3) − C7H11O8SNa(MeGlcOSO3)], 667.4 [M3Na – Na − C24H39O2(Agl) − C6H9O8SNa (GlcOSO3) − C6H10O4(Qui) − H], 519.0 [M3Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 417.1 [M3Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − NaHSO3].

3.3.6. Kuriloside I1 (6)

Colorless powder; [ α ] D 20 −5° (c 0.1, 50% MeOH). NMR: See Table 4 and Table S4, Figures S41–S47. (−)HR-ESI-MS m/z: 1749.2148 (calc. 747.2155) [M3Na − 2Na]2−, 491.8146 (calc. 491.8139) [M3Na − 3Na]3−; (−)ESI-MS/MS m/z: 1281.4 [M3Na – Na − 2CH3COOH − NaHSO4], 1197.4 [M3Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3)], 1137.4 [M3Na – Na − 2CH3COOH − C6H9O8SNa(GlcOSO3)], 859.4 [M3Na – Na − 2CH3COOH − C6H9O8SNa(GlcOSO3) − C7H11O8SNa(MeGlcOSO3)], 719.2 [M3Na − 2Na − CH3COOH]2−, 629.2 [M3Na − 2Na − NaHSO4]2−, 557.2 [M3Na − 2Na − 2CH3COOH − C6H9O8SNa(GlcOSO3)]2−.

3.3.7. Kuriloside J (7)

Colorless powder; [ α ] D 20 −10° (c 0.1, 50% MeOH). NMR: See Table 6 and Table 7, Figures S48–S56. (−)HR-ESI-MS m/z: 1377.4687 (calc. 1377.4709) [M2Na − Na], 677.2413 (calc. 677.2408) [M2Na − 2Na]2−; (−)ESI-MS/MS m/z: 1317.4 [M2Na – Na − CH3COOH], 1257.4 [M2Na – Na − NaHSO4], 1197.5 [M2Na – Na − CH3COOH − NaHSO4], 1155.4 [M2Na – Na − CH3COOH − C6H10O5(Glc)], 1039.4 [M2Na – Na − CH3COOH − C7H11O8SNa(MeGlcOSO3)], 1009.4 [M2Na – Na − CH3COOH − C6H10O5(Glc) − C6H10O4(Qui)], 889.4 [M2Na – Na − NaHSO4 − CH3COOH − C6H10O5(Glc) − C6H10O4(Qui)], 667.4 [M2Na – Na − C26H41O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − H], 519.0 [M2Na – Na − C26H41O3(Agl) − C6H10O5(Glc) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 417.1 [M2Na – Na − C26H41O3(Agl) − C6H10O5 (Glc) − C6H10O4 (Qui) − C5H8O4 (Xyl) − NaHSO3].

3.3.8. Kuriloside K (8)

Colorless powder; [ α ] D 20 −7° (c 0.1, 50% MeOH). NMR: See Table 5 and Table 8, Figures S57–S65. (−)HR-ESI-MS m/z: 1335.4573 (calc. 1335.4603) [M2Na − Na], 656.2357 (calc. 656.2356) [M2Na − 2Na]2−; (−)ESI-MS/MS m/z: 1215.4 [M2Na – Na − NaHSO4], 1159.4 [M2Na – Na − C7H12O5(MeGlc)], 1071.4 [M2Na – Na − C6H9O8SNa(GlcOSO3)], 925.4 [M2Na – Na − C6H9O8SNa (GlcOSO3) − C6H10O4 (Qui)], 895.4 [M2Na – Na − C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc)], 713.3 [M2Na – Na − C24H39O2(Agl) − C6H9O8SNa(GlcOSO3) − H], 417.1 [M2Na – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − H], 241.0 [MNa – Na − C24H39O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl) − C7H12O5(MeGlc) − H].

3.3.9. Kuriloside K1 (9)

Colorless powder; [ α ] D 20 −4° (c 0.1, 50% MeOH). NMR: See Table 7 and Table 8, Figures S66–S68. (−)HR-ESI-MS m/z: 1377.4723 (calc. 1377.4709) [M2Na − Na], 677.2426 (calc. 677.2408) [M2Na − 2Na]2−; (−)ESI-MS/MS m/z: 1317.4 [M2Na – Na − CH3COOH], 1197.5 [M2Na – Na − CH3COOH − NaHSO4], 1069.5 [M2Na – Na − C6H10O5 (Glc)], 1053.4 [M2Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3)], 877.4 [M2Na – Na − CH3COOH −C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc)], 731.3 [M2Na – Na − CH3COOH − C6H9O8SNa(GlcOSO3) − C7H12O5(MeGlc) − C6H10O4(Qui)], 565.1 [M2Na – Na − C26H41O3(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − H], 417.1 [M2Na – Na − C26H41O4(Agl) − C6H9O8SNa(GlcOSO3) − C6H10O4(Qui) − C5H8O4(Xyl)].

3.4. Cytotoxic Activity (MTT Assay)

All compounds (including cladoloside C used as the positive control) were tested in concentrations from 1.5 μM to 100 μM using two-fold dilution in dH2O. The solutions (20 µL) of tested substances in different concentrations and cell suspension (180 µL) were added in wells of 96-well plates (1 × 104 cells/well) and incubated 24 h at 37 °C and 5% CO2. After incubation, the medium with tested substances was replaced by 100 μL of fresh medium. Then, 10 μL of MTT (thiazoyl blue tertrazolium bromide) stock solution (5 mg/mL) was added to each well and the microplate was incubated for 4 h. After that, 100 μL of SDS-HCl solution (1 g SDS/10 mL dH2O/17 μL 6 N HCl) was added to each well followed by incubation for 4–18 h. The absorbance of the converted dye formazan was measured using a Multiskan FC microplate photometer (Thermo Fisher Scientific, Waltham, MA, USA) at a wavelength of 570 nm. Cytotoxic activity of the substances was calculated as the concentration that caused 50% metabolic cell activity inhibition (IC50). All the experiments were made in triplicate, p < 0.01.

3.5. Hemolytic Activity

Blood was taken from CD-1 mice (18–20 g). Erythrocytes were isolated from the blood of albino CD-1 mice by centrifugation with phosphate-buffered saline (pH 7.4) for 5 min at 4 °C by 450× g on a LABOFUGE 400R (Heraeus, Hanau, Germany) centrifuge for three times. Then, the residue of erythrocytes was resuspended in ice cold phosphate saline buffer (pH 7.4) to a final optical density of 1.5 at 700 nm, and kept on ice. For the hemolytic assay, 180 µL of erythrocyte suspension was mixed with 20 µL of test compound solution (including cladoloside C used as the positive control) in V-bottom 96-well plates. After 1 h of incubation at 37 °C, plates were exposed to centrifugation for 10 min at 900× g on a LMC-3000 (Biosan, Riga, Latvia) laboratory centrifuge. Then, we carefully selected 100 µL of supernatant and transferred it to new flat-plates respectively. Lysis of erythrocytes was determined by measuring the concentration of hemoglobin in the supernatant with a microplate photometer Multiskan FC (Thermo Fisher Scientific, Waltham, MA, USA), λ = 570 nm. The effective dose causing 50% hemolysis of erythrocytes (ED50) was calculated using the computer program SigmaPlot 10.0. All experiments were made in triplicate, p < 0.01.

3.6. Solvolytic Desulfation

A part of the glycosidic sum (350 mg) was dissolved in a mixture of pyridine/dioxane (1/1) and refluxed for 1 h. The obtained mixture was concentrated in vacuo and subsequently purified by using Si gel column chromatography (as depicted in the Section 3.3).

4. Conclusions

Thus, nine unknown earlier triterpene glycosides were isolated from the sea cucumber Thyonidium (=Duasmodactyla) kurilensis in addition to the series of kurilosides found recently [19]. Five new types of the carbohydrate chains (kurilosides of the groups G–K) were discovered. There were trisulfated penta- (kurilosides of the group I (5, 6)) and hexaosides (kuriloside H (4)) among them. Kuriloside H (4) is the second example of the most polar triterpene glycosides, along with tetrasulfated pentaosides found earlier in the sea cucumber Psolus fabricii [20]. The structures of disulfated hexa- and pentasaccharide chains of kurilosides of the groups G (3), J (7), and K (8, 9) clearly illustrate a combinatorial (mosaic) type of biosynthesis of the glycosides, namely, the positions of the sulfate group attachment. At the same time, the position of one of the sulfate groups (at C(6) Glc, attached to C(4) Xyl1) remained the same in all glycosides found in this species. Three new non-holostane aglycones lacking a lactone ring, two of them being the 22,23,24,25,26,27-hexa-nor-lanostane type and one having a normal side chain, were found in glycosides 19. The majority of the aglycones of T. kurilensis glycosides differed from each other in the substituents at C-16 (α- and β-oriented hydroxy- or acetoxy groups, or keto-group) and C-20 (hydroxy-, acetoxy-, or keto-groups), representing the biogenetically related rows of the compounds. As mentioned in a previous paper [19], the glycosides with 16α-substituents were isolated from T. kurilensis only. The finding of 16β-hydroxylated aglycones is also for the first time. Such compounds can be considered as “hot metabolites”, biosynthetic intermediates or precursors of the aglycones with the 16β-acetoxy-group.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/md19040187/s1. Table S1. NMR spectrometric data of the carbohydrate moiety of kuriloside A3 (1); Table S2. NMR spectrometric data of the aglycone moiety of kurilosides A3 (1) and G (3); Table S3. NMR spectrometric data of the carbohydrate moiety of kuriloside D1 (2); Table S4. NMR spectrometric data of the aglycone moiety of kurilosides H (4) and I1 (6); Table S5. NMR spectrometric data of the carbohydrate moiety of DS-kuriloside L (10); Table S6. NMR spectrometric data of the aglycone moiety of 10; Table S7. NMR spectrometric data of the carbohydrate moiety of DS-kuriloside M (11); Table S8. NMR spectrometric data of the aglycone moiety of 11; Figure S1. 1H NMR and 13C NMR spectra of 1; Figure S2. COSY spectrum of 1; Figure S3. HSQC spectrum of 1; Figure S4. ROESY spectrum of 1; Figure S5. HMBC spectrum of 1; Figure S6. HR-ESI-MS and ESI-MS/MS spectra of 1; Figure S7. 13C NMR spectrum of 2; Figure S8. 1H NMR spectrum of 2; Figure S9. COSY spectrum of 2; Figure S10. HSQC spectrum of 2; Figure S11. HMBC spectrum of 2; Figure S12. ROESY spectrum of 2; Figure S13. HR-ESI-MS and ESI-MS/MS spectra of 2; Figure S14. 13C NMR spectrum of 3; Figure S15. 1H NMR spectrum of 3; Figure S16. COSY spectrum of 3; Figure S17. HSQC spectrum of 3; Figure S18. HMBC spectrum of 3; Figure S19. ROESY spectrum of 3; Figure S20. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 3; Figure S21. 1 D TOCSY spectra of the MeGlc4, Glc5 and MeGlc6 of 3; Figure S22. HR-ESI-MS and ESI-MS/MS spectra of 3; Figure S23. 13C NMR spectrum of 4; Figure S24. 1H NMR spectrum of 4; Figure S25. COSY spectrum of 4; Figure S26. HSQC spectrum of 4; Figure S27. ROESY spectrum of 4; Figure S28. HMBC spectrum of 4; Figure S29. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 4; Figure S30. 1 D TOCSY spectra of Glc4, Glc5 and MeGlc6 of 4; Figure S31. HR-ESI-MS and ESI-MS/MS spectra of 4; Figure S32. 13C NMR spectrum of kuriloside I (5); Figure S33. 1H NMR spectrum of 5; Figure S34. COSY spectrum of 5; Figure S35. HSQC spectrum of 5; Figure S36. HMBC spectrum of 5; Figure S37. ROESY spectrum of 5; Figure S38. 1D TOCSY spectra of Xyl1, Qui2 and Glc3 of 5; Figure S39. 1D TOCSY spectra of Glc4 and MeGlc5 of 5; Figure S40. HR-ESI-MS and ESI-MS/MS spectra of 5; Figure S41. 13C NMR spectrum of 6; Figure S42. 1H NMR spectrum of 6; Figure S43. COSY spectrum of 6; Figure S44. HSQC spectrum of 6; Figure S45. ROESY spectrum of 6; Figure S46. HMBC spectrum of 6; Figure S47. HR-ESI-MS and ESI-MS/MS spectra of 6; Figure S48. 13C NMR spectrum of kuriloside J (7); Figure S49. 1H NMR spectrum of 7; Figure S50. COSY spectrum of 7; Figure S51. HSQC spectrum of 7; Figure S52. HMBC spectrum of 7; Figure S53. ROESY spectrum of 7; Figure S54. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 7; Figure S55. 1 D TOCSY spectra of Glc4 and MeGlc5 of 7; Figure S56. HR-ESI-MS and ESI-MS/MS spectra of 7; Figure S57. 13C NMR spectrum of kuriloside K (8); Figure S58. 1H NMR spectrum of 8; Figure S59. COSY spectrum of 8; Figure S60. HSQC spectrum of 8; Figure S61. HMBC spectrum of 8; Figure S62. ROESY spectrum of 8; Figure S63. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 8; Figure S64. 1 D TOCSY spectra of Glc4 and MeGlc5 of 8; Figure S65. HR-ESI-MS and ESI-MS/MS spectra of 8; Figure S66. 13C NMR spectrum of 9; Figure S67. 1H NMR spectrum of 9 in; Figure S68. HR-ESI-MS and ESI-MS/MS spectra of 9; Figure S69. 13C NMR spectrum of DS-kuriloside L (10); Figure S70. 1H NMR spectrum of 10; Figure S71. COSY spectrum of 10; Figure S72. HSQC spectrum of 10; Figure S73. HMBC spectrum of 10; Figure S74. ROESY spectrum of 10; Figure S75. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 10; Figure S76. HR-ESI-MS (−) and ESI-MS/MS spectra of 10; Figure S77. 13C NMR spectrum of DS-kuriloside M (11); Figure S78. 1H NMR spectrum of 11; Figure S79. COSY spectrum of 11; Figure S80. HSQC spectrum of 11; Figure S81. HMBC spectrum of 11; Figure S82. ROESY spectrum of 11; Figure S83. 1 D TOCSY spectra of Xyl1, Qui2 and Glc3 of 11; Figure S84. 1 D TOCSY spectra of Glc4 and MeGlc5 of 11; Figure S85. HR-ESI-MS (−), ESI-MS/MS spectra of 11.

Author Contributions

Conceptualization, A.S.S. and V.I.K.; Methodology, A.S.S. and S.A.A.; Investigation, A.S.S., A.I.K., S.A.A., R.S.P., P.S.D., E.A.C. and P.V.A.; Writing—original draft preparation, A.S.S. and V.I.K.; Writing—review and editing, A.S.S. and V.I.K. All authors have read and agreed to the published version of the manuscript.

Funding

The investigation was carried out with the financial support of a grant from the Ministry of Science and Education, Russian Federation 13.1902.21.0012 (075-15-2020-796) (isolation of individual triterpene glycosides) and a grant from the Russian Foundation for Basic Research No. 19-04-000-14 (elucidation of structures of the glycosides and their biotesting).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Pacific Institute of Bioorganic Chemistry (Protocol No. 0085.19.10.2020).

Acknowledgments

The study was carried out on the equipment of the Collective Facilities Center “The Far Eastern Center for Structural Molecular Research (NMR/MS) PIBOC FEB RAS”. The authors are very appreciative to Professor Valentin A. Stonik (PIBOC FEB RAS, Vladivostok, Russia) for reading and discussion of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Aminin, D.L.; Menchinskaya, E.S.; Pislyagin, E.A.; Silchenko, A.S.; Avilov, S.A.; Kalinin, V.I. Sea cucumber triterpene glyco-sides as anticancer agents. In Studies in Natural Product Chemistry; Atta-ur-Rahman, Ed.; Elsevier B.V.: Amsterdam, The Netherlands, 2016; Volume 49, pp. 55–105. [Google Scholar]
  2. Khotimchenko, Y. Pharmacological Potential of Sea Cucumbers. Int. J. Mol. Sci. 2018, 19, 1342. [Google Scholar] [CrossRef] [Green Version]
  3. Menchinskaya, E.; Gorpenchenko, T.; Silchenko, A.; Avilov, S.; Aminin, D. Modulation of Doxorubicin Intracellular Accumulation and Anticancer Activity by Triterpene Glycoside Cucumarioside A2-2. Mar. Drugs 2019, 17, 597. [Google Scholar] [CrossRef] [Green Version]
  4. Pislyagin, E.A.; Menchinskaya, E.S.; Aminin, D.L.; Avilov, S.A.; Silchenko, A.S. Sulfated Glycosides from the Sea Cucumbers Block Ca2+ Flow in Murine Neuroblastoma Cells. Nat. Prod. Commun. 2018, 13, 953–956. [Google Scholar] [CrossRef] [Green Version]
  5. Zhao, Y.-C.; Xue, C.-H.; Zhang, T.-T.; Wang, Y.-M. Saponins from Sea Cucumber and Their Biological Activities. J. Agric. Food Chem. 2018, 66, 7222–7237. [Google Scholar] [CrossRef] [PubMed]
  6. Gomes, A.R.; Freitas, A.C.; Duarte, A.C.; Rocha-Santos, T.A.P. Echinoderms: A review of bioactive compounds with poten-tial health effects. In Studies in Natural Products Chemistry; Atta-ur-Rachman, Ed.; Esevier Science B.V.: Amsterdam, The Netherlands, 2016; Volume 49, pp. 1–54. [Google Scholar]
  7. Omran, N.E.; Salem, H.K.; Eissa, S.H.; Kabbash, A.M.; Kandeil, M.A.; Salem, M.A. Chemotaxonomic study of the most abundant Egyptian sea-cucumbers using ultra-performance liquid chromatography (UPLC) coupled to high-resolution mass spectrometry (HRMS). Chemoecology 2020, 30, 35–48. [Google Scholar] [CrossRef]
  8. Kalinin, V.I.; Silchenko, A.S.; Avilov, S.A. Taxonomic significance and ecological role of triterpene glycosides from holothu-rians. Biol. Bull. 2016, 43, 532–540. [Google Scholar] [CrossRef]
  9. Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Adnryjaschenko, P.V.; Dmitrenok, P.S.; Kalinin, V.I.; Martyyas, E.A.; Minin, K.V. Fallaxosides C1, C2, D1 and D2, unusual oligosulfated triterpene glycosides from the sea cucumber Cucumaria fallax (Cu-cumariidae, Dendrochirotida, Holothurioidea) and a taxonomic stratus of this animal. Nat. Prod. Commun. 2016, 11, 939–945. [Google Scholar]
  10. Kalinin, V.I.; Avilov, S.A.; Silchenko, A.S.; Stonik, V.A. Triterpene Glycosides of Sea Cucumbers (Holothuroidea, Echinodermata) as Taxonomic Markers. Nat. Prod. Commun. 2015, 10, 21–26. [Google Scholar] [CrossRef] [Green Version]
  11. Kamyab, E.; Rohde, S.; Kellermann, M.Y.; Schupp, P.J. Chemical Defense Mechanisms and Ecological Implications of Indo-Pacific Holothurians. Molecules 2020, 25, 4808. [Google Scholar] [CrossRef]
  12. Kamyab, E.; Goebeler, N.; Kellermann, M.Y.; Rohde, S.; Reverter, M.; Striebel, M.; Schupp, P.J. Anti-Fouling Effects of Saponin-Containing Crude Extracts from Tropical Indo-Pacific Sea Cucumbers. Mar. Drugs 2020, 18, 181. [Google Scholar] [CrossRef] [Green Version]
  13. Popov, R.S.; Ivanchina, N.V.; Silchenko, A.S.; Avilov, S.A.; Kalinin, V.I.; Dolmatov, I.Y.; Stonik, V.A.; Dmitrenok, P.S. Me-tabolite profilling of triterpene glycosides of the Far Eastern sea cucumber Eupentacta fraudatrix and their distribution in va-tious body components using LC-ESI QTOF-MS. Mar. Drugs 2017, 14, 302. [Google Scholar]
  14. Park, J.-I.; Bae, H.-R.; Kim, C.G.; Stonik, V.A.; Kwak, J.Y. Relationships between chemical structures and functions of triter-pene glycosides isolated from sea cucumbers. Front. Chem. 2014, 2, 77. [Google Scholar] [CrossRef] [Green Version]
  15. Caulier, G.; Flammang, P.; Gerbaux, P.; Eeckhaut, I. When a repellent becames an attractant: Harmful saponins are kairo-mones attracting the symbiotic Harlequin crab. Sci. Rep. 2013, 3, 2639. [Google Scholar] [CrossRef] [Green Version]
  16. Claereboudt, E.J.S.; Caulier, G.; DeCroo, C.; Colson, E.; Gerbaux, P.; Claereboudt, M.R.; Schaller, H.; Flammang, P.; Deleu, M.; Eeckhaut, I. Triterpenoids in Echinoderms: Fundamental Differences in Diversity and Biosynthetic Pathways. Mar. Drugs 2019, 17, 352. [Google Scholar] [CrossRef] [Green Version]
  17. Kalinin, V.I.; Silchenko, A.S.; Avilov, S.A.; Stonik, V.A. Non-holostane aglycones of sea cucumber triterpene glycosides. Structure, biosynthesis, evolution. Steroids 2019, 147, 42–51. [Google Scholar] [CrossRef]
  18. Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Andryjashchenko, P.V.; Dmitrenok, P.S.; Kalinin, V.I.; Stonik, V.A. 3β-O-Glycosylated 16β-acetoxy-9β-H-lanosta-7,24-diene-3β,18,20β-triol, an intermediate metabolite from the sea cucumber Eupentacta fraudatrix and its biosynthetic significance. Biochem. Syst. Ecol. 2012, 44, 53–60. [Google Scholar] [CrossRef]
  19. Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Andrijaschenko, P.V.; Popov, R.S.; Dmitrenok, P.S.; Chingizova, E.A.; Kali-nin, V.I. Kurilosides A1, A2, C1, D, E and F—triterpene glycosides from the Far Eastern sea cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin): Structures with unusual non-holostane aglycones and cytotoxicities. Mar. Drugs 2020, 18, 551. [Google Scholar] [CrossRef]
  20. Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Kalinin, V.I.; Andrijaschenko, P.V.; Dmitrenok, P.S.; Popov, R.S.; Chingizova, E.A. Structures and Bioactivities of Psolusosides B1, B2, J, K, L, M, N, O, P, and Q from the Sea Cucumber Psolus fabricii. The First Finding of Tetrasulfated Marine Low Molecular Weight Metabolites. Mar. Drugs 2019, 17, 631. [Google Scholar] [CrossRef] [Green Version]
  21. Avilov, S.A.; Kalinovskii, A.I. New triterpene aglycone from the holothurian Duasmodactyla kurilensis. Chem. Nat. Compd. 1989, 25, 309–311. [Google Scholar] [CrossRef]
  22. Avilov, S.A.; Kalinovskii, A.I.; Stonik, V.A. Two new triterpene glycosides from the holothurian Duasmodactyla kurilensis. Chem. Nat. Compd. 1991, 27, 188–192. [Google Scholar] [CrossRef]
  23. Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Andryjaschenko, P.V.; Dmitrenok, P.S.; Yurchenko, E.A.; Dolmatov, I.Y.; Kalinin, V.I.; Stonik, V.A. Structure and Biological Action of Cladolosides B1, B2, C, C1, C2 and D, Six New Triterpene Glycosides from the Sea Cucumber Cladolabes schmeltzii. Nat. Prod. Commun. 2013, 8, 1527–1534. [Google Scholar] [CrossRef] [Green Version]
  24. Aminin, D.; Pislyagin, E.; Astashev, M.; Es’Kov, A.; Kozhemyako, V.; Avilov, S.; Zelepuga, E.; Yurchenko, E.; Kaluzhskiy, L.; Kozlovskaya, E.; et al. Glycosides from edible sea cucumbers stimulate macrophages via purinergic receptors. Sci. Rep. 2016, 6, 39683. [Google Scholar] [CrossRef] [Green Version]
  25. Isaeva, M.P.; Likhatskaya, G.N.; Guzev, K.V.; Baldaev, S.N.; Bystritskaya, E.P.; Stonik, V.A. Molecular cloning of sea cu-cumber oxidosqualene cyclases. Вестник Дальневoстoчнoгo oтделения Рoссийскoй академии наук 2018, 6, 84–85. [Google Scholar]
  26. Liu, H.; Kong, X.; Chen, J.; Zhang, H. De novo sequencing and transcriptome analysis of Stichpous horrens to reveal genes related to biosynthesis of triterpenoids. Aquaculture 2018, 491, 358–367. [Google Scholar] [CrossRef]
  27. Li, Y.; Wang, R.; Xun, X.; Wang, J.; Bao, L.; Thimmappa, R.; Ding, J.; Jiang, J.; Zhang, L.; Li, T.; et al. Sea cucumber genome provides insights into saponin biosynthesis and aestivation regulation. Cell Discov. 2018, 4, 85–86. [Google Scholar] [CrossRef]
  28. Cuong, N.X.; Vien, L.T.; Hoang, L.; Hanh, T.T.H.; Thao, D.T.; Thann, N.V.; Nam, N.H.; Thung, D.C.; Kiem, P.V.; Minh, C.V. Cytotoxic triterpene glycosides from the sea cucumber Stichopus horrens. Bioorganic Med. Chem. Lett. 2017, 27, 2939–2942. [Google Scholar] [CrossRef] [PubMed]
  29. Vien, L.T.; Hoang, L.; Hanh, T.T.H.; Van Thanh, N.; Cuong, N.X.; Nam, N.H.; Thung, D.C.; Van Kiem, P.; Van Minh, C. Triterpene tetraglycosides from the sea cucumber Stichopus horrens. Nat. Prod. Res. 2017, 32, 1039–1043. [Google Scholar] [CrossRef]
  30. Maltsev, I.; Stonik, V.; Kalinovsky, A.; Elyakov, G. Triterpene glycosides from sea cucumber Stichopus japonicus Selenka. Comp. Biochem. Physiol. Part B Comp. Biochem. 1984, 78, 421–426. [Google Scholar] [CrossRef]
  31. Zhang, X.-M.; Li, X.-B.; Zhang, S.-S.; He, Q.-X.; Hou, H.-R.; Dang, L.; Guo, J.-L.; Chen, Y.-F.; Yu, T.; Peng, D.-J.; et al. LC-MS/MS Identification of Novel Saponins from the Viscera of Sea Cucumber Apostichopus japonicus. Chem. Nat. Compd. 2018, 54, 721–725. [Google Scholar] [CrossRef]
Figure 1. Chemical structures of glycosides isolated from Thyonidium kurilensis: 1—kuriloside A3; 2—kuriloside D1; 3—kuriloside G; 4—kuriloside H; 5—kuriloside I; 6—kuriloside I1; 7—kuriloside J, 8—kuriloside K, 9—kuriloside K1.
Figure 1. Chemical structures of glycosides isolated from Thyonidium kurilensis: 1—kuriloside A3; 2—kuriloside D1; 3—kuriloside G; 4—kuriloside H; 5—kuriloside I; 6—kuriloside I1; 7—kuriloside J, 8—kuriloside K, 9—kuriloside K1.
Marinedrugs 19 00187 g001
Figure 2. Chemical structures of desulfated glycosides isolated from Thyonidium kurilensis: 10—DS-kuriloside L; 11—DS-kuriloside M.
Figure 2. Chemical structures of desulfated glycosides isolated from Thyonidium kurilensis: 10—DS-kuriloside L; 11—DS-kuriloside M.
Marinedrugs 19 00187 g002
Figure 3. The metabolic network of the carbohydrate chains of the glycosides from T. kurilensis.
Figure 3. The metabolic network of the carbohydrate chains of the glycosides from T. kurilensis.
Marinedrugs 19 00187 g003
Figure 4. The biosynthetic pathways to aglycones of glycosides from T. kurilensis.
Figure 4. The biosynthetic pathways to aglycones of glycosides from T. kurilensis.
Marinedrugs 19 00187 g004
Table 1. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kuriloside D1 (1).
Table 1. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kuriloside D1 (1).
PositionδC mult. aδH mult. (J in Hz) bHMBCROESY
136.0 CH21.77 brd (12.8) H-11, H-19
1.39 m H-3, H-5, H-11
226.9 CH22.20 m
1.94 brdd (11.3; 12.8) H-19
388.4 CH3.20 dd (3.8; 11.3)C: 4, 30, 31, C: 1 Xyl1H-1, H-5, H-31, H-1 Xyl1
439.7 C
552.7 CH0.90 mC: 6, 19, 30H-1, H-3, H-7, H-31
621.0 CH21.69 m
1.44 m H-8, H-19
728.2 CH1.49 m
1.28 m H-5
840.2 CH2.33 m H-18, H-19
9149.0 C
1039.4 C
11114.9 CH5.36 brd (6.0)C: 8, 10, 13H-1
1236.5 CH22.43 brd (16.5) H-17, H-32
2.20 brdd (6.0; 16.5)C: 9, 11, 14H-18, H-21
1343.7 C
1441.9 C
1548.1 CH22.27 d (16.3)C: 14, 16, 32
2.03 d (18.0)C: 13, 16, 32H-7, H-32
16216.3 C
1763.8 CH3.69 sC: 22H-12, H-21, H-32
1816.9 CH31.30 sC: 17H-8, H-12, H-15, H-19, H-21
1922.2 CH31.12 sC: 1, 5, 9, 10H-1, H-2, H-6, H-8
2080.8 C
2124.7 CH31.61 sC: 17, 20, 22H-12, H-17, H-18, H-23
22217.6 C
2332.2 CH23.67 dd (10.6; 18.2)C: 22, 24H-26, H-27
3.43 dt (7.8; 18.2)C: 22, 24H-21, H-26, H-27
2438.0 CH22.27 t (7.8)C: 22, 23, 25, 26, 27
2569.0 C
2630.0 CH31.42 sC: 24, 25, 27H-23, H-24, H-27
2729.5 CH31.41 sC: 24, 25, 26H-23, H-24, H-26
3016.5 CH31.06 sC: 3, 4, 5, 31H-2, H-6, H-31
3127.9 CH31.26 sC: 3, 4, 5, 30H-3, H-5, H-6, H-30, H-1 Xyl1
3218.6 CH30.89 sC: 8, 13, 14, 15H-7, H-12, H-15, H-17
a Recorded at 176.03 MHz in C5D5N/D2O (4/1). b Recorded at 700.00 MHz in C5D5N/D2O (4/1).
Table 2. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside G (3).
Table 2. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside G (3).
AtomδC mult.a,b,cδH mult. (J in Hz) dHMBCROESY
Xyl1 (1→C-3)
1104.7 CH4.65 d (7.8)C: 3H-3; H-3, 5 Xyl1
282.2 CH3.95 t (8.8)C: 1 Qui2H-1 Qui2; H-4 Xyl1
375.1 CH4.15 t (8.8)C: 4 Xyl1H-5 Xyl1
477.6 CH4.15 m H-1 Glc5
563.5 CH24.36 dd (5.4; 10.8)
3.61 m H-1 Xyl1
Qui2 (1→2Xyl1)
1104.4 CH5.03 d (7.8)C: 2 Xyl1H-2 Xyl1; H-3, 5 Qui2
275.2 CH3.89 t (7.8)C: 3 Qui2
375.2 CH3.99 t (9.3)C: 4 Qui2
486.4 CH3.56 t (9.3)C: 1 Glc3H-1 Glc3; H-2 Qui2
571.4 CH3.69 dd (6.2; 9.3) H-1 Qui2
617.9 CH31.64 d (6.2)C: 4, 5 Qui2
Glc3 (1→4Qui2)
1104.0 CH4.85 d (8.1)C: 4 Qui2H-4 Qui2; H-3, 5 Glc3
273.5 CH3.90 t (8.1)
387.5 CH4.12 t (8.1)C: 4 Glc3H-1 MeGlc4; H-1, 5 Glc3
469.3 CH3.84 t (8.1)C: 5 Glc3
577.5 CH3.90 t (8.1)
661.6 CH24.34 d (11.6)
4.03 dd (7.0; 11.6)
MeGlc4 (1→3Glc3)
1104.8 CH5.12 d (8.1)C: 3 Glc3H-3 Glc3; H-3, 5 MeGlc4
274.5 CH3.79 t (8.1)
386.3 CH3.65 t (8.1)C: 4 MeGlc4; OMeH-1 MeGlc4
469.9 CH3.98 t (8.1)C: 3, 5 MeGlc4
575.5 CH4.04 t (8.1) H-1 MeGlc4
667.0 CH24.97 d (11.6)
4.73 dd (4.7; 11.6)
OMe60.5 CH33.76 sC: 3 MeGlc4
Glc5 (1→4Xyl1)
1102.1 CH4.87 d (7.0)C: 4 Xyl1H-4 Xyl1; H-3, 5 Glc5
273.2 CH3.84 t (8.1)C: 1, 3 Glc5
385.9 CH4.16 t (8.1)C: 1 MeGlc6; C: 2, 4 Glc5H-1 MeGlc6; H-1 Glc5
469.2 CH3.91 t (9.3)C: 5 Glc5H-6 Glc5
575.5 CH4.02 m H-1 Glc5
667.1 CH24.93 d (11.6)
4.69 dd (5.8; 11.6)C: 5 Glc5
MeGlc6 (1→3Glc5)
1104.4 CH5.19 d (8.1)C: 3 Glc5H-3 Glc5; H-3, 5 MeGlc6
274.3 CH3.84 t (8.1)
386.9 CH3.66 t (8.1)OMeH-1 MeGlc6
470.2 CH3.89 t (8.1)C: 5 MeGlc6
577.5 CH3.90 t (8.1) H-1 MeGlc6
661.7 CH24.34 d (11.6)
4.06 dd (5.8; 11.6)
OMe60.5 CH33.80 sC: 3 MeGlc6
a Recorded at 176.03 MHz in C5D5N/D2O (4/1). b Bold = interglycosidic positions. c Italic = sulfate position. d Recorded at 700.00 MHz in C5D5N/D2O (4/1). Multiplicity by 1D TOCSY.
Table 3. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside H (4).
Table 3. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside H (4).
AtomδC mult. a,b,cδH mult. (J in Hz) dHMBCROESY
Xyl1 (1→C-3)
1104.7 CH4.63 d (8.3)C: 3H-3; H-3, 5 Xyl1
282.6 CH3.83 t (7.1)C: 1 Qui2H-1 Qui2; H-4 Xyl1
375.1 CH4.05 mC: 4 Xyl1H-1, 5 Xyl1
479.4 CH4.04 m H-1 Glc5
563.5 CH24.34 brd (10.1)C: 3 Xyl1
3.59 m H-1 Xyl1
Qui2 (1→2Xyl1)
1104.5 CH4.88 d (7.1)C: 2 Xyl1H-2 Xyl1; H-3, 5 Qui2
275.4 CH3.88 t (8.9)C: 1, 3 Qui2H-4 Qui2
374.9 CH3.98 t (8.9) H-1, 5 Qui2
486.5 CH3.35 t (8.9)C: 1 Glc3H-1 Glc3; H-2 Qui2
571.4 CH3.63 dd (5.9; 8.9) H-1, 3 Qui2
617.6 CH31.58 d (5.8)C: 4, 5 Qui2
Glc3 (1→4Qui2)
1104.1 CH4.72 d (8.5)C: 4 Qui2H-4 Qui2; H-3, 5 Glc3
273.4 CH3.83 t (8.5)
386.3 CH4.18 t (8.5)C: 1 Glc4; C: 2, 4 Glc3H-1 Glc4; H-1, 5 Glc3
469.3 CH3.76 t (8.5)C: 5, 6 Glc3
574.7 CH4.10 mC: 4 Glc3H-1 Glc3
667.6 CH24.96 d (11.0)
4.57 d (11.0)
Glc4 (1→3Glc3)
1104.5 CH5.21 d (8.5)C: 3 Glc3H-3 Glc3; H-3, 5 Glc4
274.7 CH3.93 t (8.5)C: 1, 3 Glc4
377.7 CH4.11 t (8.5)C: 4 MeGlc4H-1, 5 Glc4
471.0 CH3.94 t (8.5)
577.7 CH3.89 m H-1 Glc4
661.9 CH24.37 d (12.3)
4.06 dd (6.2; 12.3)
Glc5 (1→4Xyl1)
1102.8 CH4.85 d (8.6)C: 4 Xyl1H-4 Xyl1; H-3, 5 Glc5
273.2 CH3.83 t (8.6)C: 1, 3 Glc5
386.3 CH4.13 t (8.6)C: 1 MeGlc6; C: 2 Glc5H-1 MeGlc6; H-1 Glc5
469.2 CH3.76 t (8.6) H-6 Glc5
577.2 CH4.09 t (8.6) H-1 Glc5
667.4 CH24.96 d (11.1)
4.56 d (11.1) H-4 Glc5
MeGlc6 (1→3Glc5)
1104.4 CH5.13 d (7.4)C: 3 Glc5H-3 Glc5; H-3, 5 MeGlc6
274.3 CH3.78 t (7.4)C: 1 MeGlc6H-4 MeGlc6
386.1 CH3.63 t (8.6)C: 4 MeGlc6; OMeH-1, 5 MeGlc6; OMe
469.8 CH4.00 t (8.6)C: 3, 5 MeGlc6
575.6 CH4.00 m H-1, 3 MeGlc6
667.0 CH24.93 d (9.9)
4.75 dd (3.7; 11.1) H-4 MeGlc6
OMe60.4 CH33.75 sC: 3 MeGlc6
a Recorded at 176.04 MHz in C5D5N/D2O (4/1). b Bold = interglycosidic positions. c Italic = sulfate position. d Recorded at 700.13 MHz in C5D5N/D2O (4/1). Multiplicity by 1D TOCSY.
Table 4. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kurilosides I (5) and I1 (6).
Table 4. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kurilosides I (5) and I1 (6).
AtomδC mult. a,b,cδH mult. (J in Hz) dHMBCROESY
Xyl1 (1→C-3)
1104.7 CH4.63 d (6.6)C: 3H-3; H-3, 5 Xyl1
282.1 CH3.90 t (6.6)C: 1 Qui2H-1 Qui2
375.1 CH4.10 t (6.6)C: 4 Xyl1
478.5 CH4.10 t (6.6) H-1 Glc4
563.4 CH24.34 dd (9.6; 11.7)C: 3 Xyl1
3.59 t (11.2) H-1 Xyl1
Qui2 (1→2Xyl1)
1104.4 CH4.96 d (7.1)C: 2 Xyl1H-2 Xyl1; H-5 Qui2
275.4 CH3.84 t (8.3)C: 1, 3 Qui2H-4 Qui2
374.9 CH3.93 t (8.3)C: 2, 4 Qui2H-1, 5 Qui2
487.0 CH3.36 t (8.3)C: 1 Glc3; C: 5, 6 Qui2H-1 Glc3
571.3 CH3.65 dd (5.9; 9.5)C: 6 Qui2H-1, 3 Qui2
617.7 CH31.59 d (5.9)C: 4, 5 Qui2
Glc3 (1→4Qui2)
1104.7 CH4.69 d (7.8)C: 4 Qui2H-4 Qui2; H-5 Glc3
274.1 CH3.80 t (8.6)C: 1, 3 Glc3
376.9 CH4.11 t (8.6)C: 2, 4 Glc3
470.8 CH3.89 t (8.6)C: 3, 5, 6 Glc3H-2, 6 Glc3
575.5 CH4.09 t (8.6)
667.6 CH25.05 brd (9.5)
4.64 dd (7.8; 12.1)C: 5 Glc3
Glc4 (1→4Xyl1)
1102.4 CH4.85 d (7.8)C: 4 Xyl1H-4 Xyl1; H-5 Glc4
273.1 CH3.82 t (8.6)C: 1 Glc4
386.3 CH4.12 t (8.6)C: 1 MeGlc5; C: 4 Glc4H-1 MeGlc5
469.2 CH3.81 t (8.6)C: 3, 5, 6 Glc4
574.9 CH4.06 t (8.6) H-1 Glc4
667.4 CH24.95 d (10.3)
4.61 dd (5.2; 10.3)
MeGlc5 (1→3Glc4)
1104.5 CH5.13 d (7.8)C: 3 Glc4H-3 Glc4; H-3, 5 MeGlc5
274.2 CH3.77 t (8.6)C: 1, 3 MeGlc5H-4 MeGlc5
386.3 CH3.62 t (8.6)C: 2, 4 MeGlc5; OMeH-1, 5 MeGlc5; OMe
469.8 CH4.00 t (8.6)C: 3, 5 MeGlc5H-2, 6 MeGlc5
575.4 CH4.01 t (8.6) H-1 MeGlc5
667.0 CH24.92 d (10.3)C: 4, 5 MeGlc5
4.74 dd (3.5; 10.3)C: 5 MeGlc5
OMe60.4 CH33.75 sC: 3 MeGlc5
a Recorded at 176.04 MHz in C5D5N/D2O (4/1). b Bold = interglycosidic positions. c Italic = sulfate position. d Recorded at 700.13 MHz in C5D5N/D2O (4/1). Multiplicity by 1D TOCSY.
Table 5. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kurilosides I (5) and K (8).
Table 5. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kurilosides I (5) and K (8).
PositionδC mult. aδH mult. (J in Hz) bHMBCROESY
136.2 CH21.67 m H-11, H-30
1.28 m H-3, H-11
226.8 CH22.07 m
1.83 brd (11.3) H-19, H-30
388.7 CH3.09 dd (4.2; 11.3)C: 31, C: 1 Xyl1H-5, H-31, H1-Xyl1
439.6 C
552.8 CH0.75 brd (12.5)C: 6, 7, 30H-3, H-7, H-31
621.1 CH21.56 m H-31
1.28 dt (2.4; 12.5) H-8, H-30
728.0 CH21.52 m
1.17 m H-5, H-32
841.2 CH2.14 m H-18, H-19
9148.6 C
1039.1 C
11114.3 CH5.15 brd (6.0)C: 10, 12, 14H-1
1236.4 CH21.98 brdd (3.0; 16.7) H-32
1.68 brd (16.7)C: 9, 11H-8, H-18, H-21
1345.1 C
1443.2 C
1545.0 CH22.07 dd (7.8; 12.5)C: 14, 17, 32H-32
1.70 d (6.0; 12.5)C: 13, 14, 16, 32
1672.8 CH4.82 dd (7.1; 14.9)C: 14H-17, H-32
1757.2 CH2.11 mC: 14, 18, 20, 21H-21, H-32
1816.0 CH30.86 sC: 12, 14, 15, 17H-8, H-12, H-20, H-21
1922.2 CH30.97 sC: 1, 5, 9, 10H-1, H-2, H-8, H-18
2066.5 CH4.38 dd (6.0; 9.5)C: 16, 17H-18, H-21
2122.7 CH31.40 d (6.0)C: 17, 20H-12, H-17, H-18, H-20
3016.5 CH30.96 sC: 3, 4, 5, 31H-2, H-6, H-31, H-6 Qui2
3127.9 CH31.12 sC: 3, 4, 5, 30H-3, H-5, H-6, H-30, H-1 Xyl1
3218.8 CH30.67 sC: 8, 13, 14, 15H-7, H-15, H-17
a Recorded at 176.03 MHz in C5D5N/D2O (4/1). b Recorded at 700.00 MHz in C5D5N/D2O (4/1).
Table 6. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside J (7).
Table 6. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of carbohydrate moiety of kuriloside J (7).
AtomδC mult. a,b,cδH mult. (J in Hz) dHMBCROESY
Xyl1 (1→C-3)
1104.4 CH4.65 d (7.6)C: 3H-3; H-3, 5 Xyl1
282.1 CH3.97 t (7.6)C: 1 Qui2H-1 Qui2
375.1 CH4.15 t (7.3)C: 4 Xyl1
477.5 CH4.15 t (7.3)C: 3 Xyl1H-1 Glc4
563.4 CH24.36 brd (9.3)
3.60 m H-1, 3 Xyl1
Qui2 (1→2Xyl1)
1104.5 CH5.07 d (7.9)C: 2 Xyl1H-2 Xyl1; H-5 Qui2
275.5 CH3.91 t (7.9)C: 1 Qui2H-4 Qui2
375.1 CH4.04 t (8.8)C: 2, 4 Qui2H-1 Qui2
486.3 CH3.56 t (8.8)C: 1 Glc3; C: 5, 6 Qui2H-1 Glc3; H-2 Qui2
571.3 CH3.71 m H-1, 3 Qui2
617.8 CH31.65 d (6.2)C: 4, 5 Qui2
Glc3 (1→4Qui2)
1104.6 CH4.84 d (7.2)C: 4 Qui2H-4 Qui2; H-3, 5 Glc3
274.2 CH3.91 t (7.9)C: 1 Glc3
377.3 CH4.16 t (7.9)C: 4 Glc3H-1 Glc3
470.9 CH3.98 t (7.9)
577.7 CH3.95 m H-1, 3 Glc3
661.8 CH24.44 dd (2.0; 11.9)
4.11 dd (5.8; 11.2)
Glc4 (1→4Xyl1)
1102.0 CH4.87 d (7.9)C: 4 Xyl1H-4 Xyl1; H-5 Glc4
272.9 CH3.82 t (8.4)C: 1 Glc4
386.3 CH4.10 t (8.4)C: 1 MeGlc5; C: 4 Glc4H-1 MeGlc5; H-1 Glc4
469.0 CH3.86 m
575.1 CH4.05 m H-1 Glc4
667.1 CH24.98 m
4.69 m
MeGlc5 (1→3Glc4)
1104.7 CH5.12 d (7.8)C: 3 Glc4H-3 Glc4; H-3, 5 MeGlc5
274.3 CH3.78 t (7.8) H-4 MeGlc5
386.3 CH3.62 t (7.8)C: 2, 4 MeGlc5; OMeH-1, 5 MeGlc5; OMe
469.7 CH4.04 mC: 3, 5 MeGlc5
575.5 CH3.99 m H-1, 3 MeGlc5
666.7 CH24.96 d (10.5)
4.79 dd (4.2; 10.5)
OMe60.2 CH33.75 sC: 3 MeGlc5
a Recorded at 176.04 MHz in C5D5N/D2O (4/1). b Bold = interglycosidic positions. c Italic = sulfate position. d Recorded at 700.13 MHz in C5D5N/D2O (4/1). Multiplicity by 1D TOCSY.
Table 7. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kuriloside J (7) and K1 (9).
Table 7. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the aglycone moiety of kuriloside J (7) and K1 (9).
PositionδC mult. aδH mult. (J in Hz) bHMBCROESY
136.0 CH21.71 m H-11, H-19
1.33 m H-3, H-5, H-11
226.6 CH22.10 m
1.86 m H-30
388.5 CH3.12 dd (4.2; 11.6) H1-Xyl1
439.5 C
552.6 CH0.79 brd (11.8) H-1, H-3, H-31
620.9 CH21.61 m
1.40 m
727.8 CH21.51 m
1.18 m H-5, H-32
841.1 CH2.13 m H-15, H-18, H-19
9148.6 C
1039.0 C
11114.2 CH5.19 m H-1
1235.8 CH22.01 m H-17, H-32
1.77 brdd (5.3; 16.2)
1345.2 C
1443.3 C
1543.9 CH22.15 mC: 14H-32
1.36 mC: 13H-18
1675.1 CH5.76 m H-32
1756.2 CH2.29 brt (7.9; 10.0)C: 20H-12, H-21, H-32
1815.1 CH30.77 sC: 12, 13, 14, 17H-8, H-12, H-15, H-20
1922.0 CH31.05 sC: 1, 5, 9, 10H-1, H-2, H-8, H-18
2064.8 CH4.28 dd (6.4; 10.0) H-18, H-21
2123.1 CH31.42 d (6.4)C: 17, 20H-12, H-17, H-18, H-20
3016.4 CH31.01 sC: 3, 4, 5, 31H-2, H-6, H-31
3127.8 CH31.16 sC: 3, 4, 5, 30H-3, H-5, H-6, H-30
3218.8 CH30.67 sC: 8, 13, 14, 15H-7, H-17
OAc21.1 CH32.17 sOAc
171.2 C
a Recorded at 176.03 MHz in C5D5N/D2O (4/1). b Recorded at 700.00 MHz in C5D5N/D2O (4/1).
Table 8. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the carbohydrate moiety of kurilosides K (8) and K1 (9).
Table 8. 13C and 1H NMR chemical shifts, HMBC, and ROESY correlations of the carbohydrate moiety of kurilosides K (8) and K1 (9).
AtomδC mult. a,b,cδH mult. (J in Hz) dHMBCROESY
Xyl1 (1→C-3)
1104.7 CH4.62 d (6.8)C: 3H-3; H-3, 5 Xyl1
282.2 CH3.88 t (7.6)C: 1 Qui2; C: 1 Xyl1H-1 Qui2
375.0 CH4.07 t (7.6)C: 2, 4 Xyl1H-1 Xyl1
478.9 CH4.06 m H-1 Glc4
563.4 CH24.32 dd (7.6; 11.4)
3.60 m H-1 Xyl1
Qui2 (1→2Xyl1)
1104.5 CH4.93 d (8.5)C: 2 Xyl1H-2 Xyl1; H-3, 5 Qui2
275.4 CH3.84 t (8.5)C: 1, 3 Qui2H-4 Qui2
374.5 CH3.93 t (8.5)C: 2, 4 Qui2H-5 Qui2
486.9 CH3.35 t (8.5)C: 1 Glc3; C: 3, 5 Qui2H-1 Glc3; H-2 Qui2
571.3 CH3.65 m H-1, 3 Qui2
617.7 CH31.60 d (5.3)C: 4, 5 Qui2
Glc3 (1→4Qui2)
1104.8 CH4.69 d (6.5)C: 4 Qui2H-4 Qui2; H-3, 5 Glc3
274.1 CH3.81 t (8.4)C: 1, 3 Glc3
376.9 CH4.11 t (8.4)C: 2, 4 Glc3
470.8 CH3.88 t (8.4)C: 3, 5, 6 Glc3
575.4 CH4.10 m H-1 Glc3
667.6 CH25.08 brd (11.2)
4.64 dd (8.4; 11.2) C: 5 Glc3
Glc4 (1→4Xyl1)
1102.7 CH4.84 d (7.5)C: 4 Xyl1H-4 Xyl1; H-3, 5 Glc4
273.2 CH3.83 mC: 1, 3 Glc4
386.0 CH4.16 t (8.4)9C: 1 MeGlc5; C: 2, 4 Glc4H-1 MeGlc5
469.1 CH3.83 mC: 5, 6 Glc4
574.8 CH4.05 m H-1 Glc4
667.3 CH24.96 d (10.9)
4.61 m
MeGlc5 (1→3Glc4)
1104.4 CH5.19 d (7.2)C: 3 Glc4H-3 Glc4; H-3, 5 MeGlc5
275.1 CH3.85 t (8.9)C: 1, 3 MeGlc5
386.9 CH3.66 t (8.9)C: 2, 4 MeGlc5; OMeH-1 MeGlc5; OMe
470.2 CH3.90 t (8.9)C: 5 MeGlc5
577.5 CH3.89 mC: 6 MeGlc5H-1 MeGlc5
661.6 CH24.36 brd (12.5)
4.07 dd (5.4; 12.5)C: 5 MeGlc5
OMe60.5 CH33.79 sC: 3 MeGlc5
a Recorded at 176.04 MHz in C5D5N/D2O (4/1). b Bold = interglycosidic positions. c Italic = sulfate position. d Recorded at 700.13 MHz in C5D5N/D2O (4/1). Multiplicity by 1D TOCSY.
Table 9. The cytotoxic activities of glycosides 19 and cladoloside C (positive control) against mouse erythrocytes, neuroblastoma Neuro 2a cells, and normal epithelial JB-6 cells.
Table 9. The cytotoxic activities of glycosides 19 and cladoloside C (positive control) against mouse erythrocytes, neuroblastoma Neuro 2a cells, and normal epithelial JB-6 cells.
GlycosideED50, µMCytotoxicity EC50, µM
ErythrocytesJB-6Neuro-2a
Kuriloside A3 (1)>100.00>100.00>100.00
Kuriloside D1 (2)>100.00>100.00>100.00
Kuriloside G (3)76.26 ± 0.98>100.00>100.00
Kuriloside H (4)6.85 ± 0.674.63 ± 0.0838.28 ± 1.15
Kuriloside I (5)>100.00>100.00>100.00
Kuriloside I1 (6)10.34 ± 0.2811.48 ± 1.0256.63 ± 0.98
Kuriloside J (7)47.61 ± 1.7377.75 ± 0.27>100.00
Kuriloside K (8)>100.00>100.00>100.00
Kuriloside K1 (9)20.97 ± 0.3937.44 ± 0.13>100.00
Cladoloside C
(positive control)
0.54 ± 0.016.38 ± 0.089.54 ± 0.82
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Silchenko, A.S.; Kalinovsky, A.I.; Avilov, S.A.; Andrijaschenko, P.V.; Popov, R.S.; Dmitrenok, P.S.; Chingizova, E.A.; Kalinin, V.I. Triterpene Glycosides from the Far Eastern Sea Cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin): The Structures, Cytotoxicities, and Biogenesis of Kurilosides A3, D1, G, H, I, I1, J, K, and K1. Mar. Drugs 2021, 19, 187. https://doi.org/10.3390/md19040187

AMA Style

Silchenko AS, Kalinovsky AI, Avilov SA, Andrijaschenko PV, Popov RS, Dmitrenok PS, Chingizova EA, Kalinin VI. Triterpene Glycosides from the Far Eastern Sea Cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin): The Structures, Cytotoxicities, and Biogenesis of Kurilosides A3, D1, G, H, I, I1, J, K, and K1. Marine Drugs. 2021; 19(4):187. https://doi.org/10.3390/md19040187

Chicago/Turabian Style

Silchenko, Alexandra S., Anatoly I. Kalinovsky, Sergey A. Avilov, Pelageya V. Andrijaschenko, Roman S. Popov, Pavel S. Dmitrenok, Ekaterina A. Chingizova, and Vladimir I. Kalinin. 2021. "Triterpene Glycosides from the Far Eastern Sea Cucumber Thyonidium (=Duasmodactyla) kurilensis (Levin): The Structures, Cytotoxicities, and Biogenesis of Kurilosides A3, D1, G, H, I, I1, J, K, and K1" Marine Drugs 19, no. 4: 187. https://doi.org/10.3390/md19040187

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop